http://www.pharmajournalist.com/xtandi-enzalutamide-demonstrates-significant-improvement-in-overall-survival-in-phase-3-prosper-trial-of-patients-with-nmcrpc/ 2020-02-14T11:18:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/lilly-announces-topline-results-for-solanezumab-from-the-dian-tu-study/ 2020-02-14T11:22:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/advaxis-and-personalis-announce-research-agreement-to-deploy-immunoid-next-platform-in-the-adxs-503-clinical-program/ 2020-02-14T11:40:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Advaxis-Logo.jpeg http://www.pharmajournalist.com/cannabics-pharmaceuticals-collaborates-with-rckmc-to-develop-cannabis-strains-targeting-gastrointestinal-cancers/ 2020-02-14T11:43:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Cannabics-Logo.jpg http://www.pharmajournalist.com/fda-grants-soligenix-fast-track-designation-for-rivax-in-the-prevention-of-ricin-poisoning/ 2020-02-14T12:08:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/seattle-genetics-gets-fda-priority-review-for-tucatinib-in-locally-advanced-or-metastatic-her2-positive-breast-cancer/ 2020-02-14T12:10:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Seattle-Childrens.jpg http://www.pharmajournalist.com/alx-oncology-announces-closing-of-105-million-series-c-financing/ 2020-02-14T12:12:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ALX-Oncology-Logo.jpg http://www.pharmajournalist.com/mercks-keytruda-plus-chemotherapy-meets-primary-endpoint-in-mtnbc-trial/ 2020-02-14T12:14:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/novartis-capmatinib-gets-fda-priority-review-in-metex14-mutated-advanced-nsclc/ 2020-02-14T12:17:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/dr-reddys-laboratories-to-acquire-select-business-divisions-of-wockhardt-in-india/ 2020-02-14T12:18:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/ligand-agrees-to-acquire-core-assets-partnered-programs-and-ion-channel-technologies-from-icagen/ 2020-02-14T12:20:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/biohavens-troriluzole-study-for-generalized-anxiety-disorder-gad-misses-primary-endpoint/ 2020-02-14T12:29:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Biohaven-Pharma-Logo.png http://www.pharmajournalist.com/lakepharma-and-nj-bio-form-strategic-alliance-to-provide-streamlined-antibody-drug-conjugate-services/ 2020-02-14T12:35:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/LakePharma-Logo.png http://www.pharmajournalist.com/catalent-completes-acquisition-of-masthercell/ 2020-02-14T12:39:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/pci-pharma-services-announces-the-acquisition-of-bellwyck-pharma-services/ 2020-02-14T12:45:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg http://www.pharmajournalist.com/comar-to-expand-west-coast-footprint/ 2020-02-14T13:03:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/comar-image.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/02/comar-image.jpg http://www.pharmajournalist.com/reform-biologics-and-milliporesigma-announce-a-licensing-agreement-for-excipient-development-and-commercialization/ 2020-02-14T13:33:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ReForm-Biologics-Logo.jpg http://www.pharmajournalist.com/forma-therapeutics-announces-ft-4202-granted-fast-track-designation-and-rare-pediatric-disease-designation-for-treatment-of-sickle-cell-disease/ 2020-02-21T09:21:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/humanetics-corporation-acquires-manufacturing-assets-for-radioprotectant-drug/ 2020-02-21T09:25:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Humanetics-Logo.png http://www.pharmajournalist.com/european-commission-approves-vyndaqel-the-first-treatment-in-the-eu-for-transthyretin-amyloid-cardiomyopathy-attr-cm/ 2020-02-21T09:29:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/audentes-therapeutics-to-build-gene-therapy-manufacturing-facility-in-north-carolina/ 2020-02-21T09:34:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Audentes-Therapeutics.jpg http://www.pharmajournalist.com/pharmamar-and-jazz-announce-fda-acceptance-and-priority-review-of-new-drug-application-for-lurbinectedin-in-relapsed-small-cell-lung-cancer/ 2020-02-21T09:36:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/pharmamar1.jpg http://www.pharmajournalist.com/oxford-globals-formulation-delivery-newsletter/ 2020-02-21T09:38:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Website-BLast-2.png http://www.pharmajournalist.com/wp-content/uploads/2020/02/Website-BLast-2.png http://www.pharmajournalist.com/fda-approves-gsks-voltaren-arthritis-pain-for-over-the-counter-use-in-the-united-states/ 2020-02-21T09:41:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ascletis-ind-filing-for-its-non-alcoholic-steatohepatitis-nash-drug-accepted-by-nmpa/ 2020-02-21T09:44:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ascletis-logo.jpg http://www.pharmajournalist.com/novartis-receives-ec-approval-for-beovu-a-next-generation-anti-vegf-treatment-for-wet-amd-a-leading-cause-of-blindness-worldwide/ 2020-02-21T09:48:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/vifor-pharma-and-fresenius-kabi-create-joint-venture-in-china-for-i-v-iron-portfolio/ 2020-02-21T10:04:12+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Vifor-Pharma-Logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-tecentriq-monotherapy-as-first-line-treatment-of-certain-people-with-advanced-non-small-cell-lung-cancer/ 2020-02-21T10:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/neotx-closes-45-million-series-c-financing/ 2020-02-21T10:09:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/NeoTX-Logo.jpg http://www.pharmajournalist.com/sanofi-joins-forces-with-u-s-department-of-health-and-human-services-to-advance-a-novel-coronavirus-vaccine/ 2020-02-21T10:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-gsks-voltaren-arthritis-pain-for-over-the-counter-use-in-the-united-states-2/ 2020-02-21T10:16:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/zydus-cadila-launches-a-fast-tracked-programme-to-develop-vaccine-for-the-novel-coronavirus-2019-ncov-covid-19/ 2020-02-21T10:21:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Zydus.jpg http://www.pharmajournalist.com/m8-and-vectans-signed-an-exclusive-licensing-agreement-of-loramyc-miconazole-lauriad-for-mexico-and-brazil/ 2020-02-21T10:25:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/nimble-announces-collaboration-with-genentech-to-discover-and-develop-novel-peptide-based-therapeutics/ 2020-02-21T10:28:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/nimble-therapeutics-logo.jpg http://www.pharmajournalist.com/five-prime-therapeutics-licenses-antibodies-to-seattle-genetics-for-use-in-novel-adc-programs/ 2020-02-21T10:29:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/five-prime-therapeutics-inc-lo.png http://www.pharmajournalist.com/immatics-and-gsk-partner-to-develop-novel-adoptive-cell-therapies/ 2020-02-21T10:32:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/immatics-logo.jpg http://www.pharmajournalist.com/hummingbird-bioscience-announces-agreement-with-mycenax-biotech/ 2020-02-21T10:35:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Hummingbird-Bioscience-Logo.jpg http://www.pharmajournalist.com/univercells-secures-up-to-e50m-investment-from-kkr-platform-to-speed-delivery-of-manufacturing-technologies/ 2020-02-21T10:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/univercells_logo.png http://www.pharmajournalist.com/st-louis-startup-pluton-biosciences-acquires-microbe-inotech-laboratories-inc/ 2020-02-21T10:40:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/pluton-ceo-charlie.jpg https://pharmajournalist.com/wp-content/uploads/2020/02/pluton-ceo-charlie.jpg http://www.pharmajournalist.com/aphena-expands-bottling-capacity-with-addition-of-new-line/ 2020-02-21T10:44:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Aphena.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/02/Aphena.jpg http://www.pharmajournalist.com/good-laboratory-practices-software-upgrade-for-biotage-extrahera/ 2020-02-21T11:09:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/harbour-biomed-announces-completion-of-phase-1-study-in-china-of-hbm9161-an-anti-fcrn-antibody/ 2020-02-21T11:15:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/exclusive-interview-with-martin-everett-cso-antabio-ahead-of-the-superbugs-superdrugs-conference/ 2020-02-21T11:18:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Superbugs-Superdrugs-2020.jpg http://www.pharmajournalist.com/lumacyte-expands-into-europe-tackling-expansive-vaccine-and-cell-and-gene-therapy-markets/ 2020-02-21T11:22:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/LumaCyte-Logo.png http://www.pharmajournalist.com/cellectis-and-servier-expand-collaboration-on-ucart19-products/ 2020-02-21T11:27:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Cellectis-Logo.png http://www.pharmajournalist.com/arrevus-receives-fda-orphan-drug-designation-for-arv-1801-sodium-fusidate/ 2020-02-21T11:30:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Arrevus-Logo.png http://www.pharmajournalist.com/exclusive-interview-with-pharma-microbiology-boston-conference-chair-lynne-ensor-speaks-about-coronavirus/ 2020-02-21T12:02:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/P-316-Pharma-Microbiology-EC-300-x-250.jpg http://www.pharmajournalist.com/regulatory-outlook-for-the-injectable-drug-delivery-space/ 2020-02-25T10:28:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Injectable-drug-delivery.jpg http://www.pharmajournalist.com/report-on-the-8th-edition-of-biofit-in-marseille-december-10-11-2019/ 2020-02-26T12:04:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/BIOFIT-2020-banners-300x250-px.jpg http://www.pharmajournalist.com/janssen-pharmaceutical-exclusive-interview-released-ahead-of-pre-filled-syringes-east-coast-2020/ 2020-02-27T08:08:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Pre-filled-Syringes-East-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/sandoz-to-keep-prices-stable-for-potential-coronavirus-drugs/ 2020-02-28T10:30:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/novavax-advances-development-of-novel-covid-19-vaccine/ 2020-02-28T10:34:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/gilead-initiates-two-phase-3-studies-of-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19/ 2020-02-28T10:37:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-forms-alliance-to-develop-covid-19-vaccine/ 2020-02-28T10:42:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Tonix-Pharma-Logo.png http://www.pharmajournalist.com/takeda-acquires-pvp-biologics-following-results-of-a-phase-1-study-of-tak-062-kuma062-for-the-treatment-of-celiac-disease/ 2020-02-28T10:46:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/bicycle-therapeutics-and-genentech-sign-1-7bn-cancer-therapies-deal/ 2020-02-28T10:49:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/vir-biotechnology-and-wuxi-biologics-announce-collaboration-for-global-development-of-antibodies-to-treat-covid-19/ 2020-02-28T11:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/stada-becomes-a-major-consumer-healthcare-player-by-acquiring-15-well-established-gsk-brands/ 2020-02-28T11:06:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/STADA.jpg http://www.pharmajournalist.com/moderna-ships-mrna-vaccine-against-novel-coronavirus-mrna-1273-for-phase-1-study/ 2020-02-28T11:09:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/sanofi-to-create-new-industry-leading-european-company-to-provide-api/ 2020-02-28T11:13:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/novartis-and-dndi-to-collaborate-on-the-development-of-a-new-oral-drug-to-treat-visceral-leishmaniasis/ 2020-02-28T11:14:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/astrazeneca-divests-global-rights-to-movantik/ 2020-02-28T11:17:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novartis-seeks-approval-for-ofatumumab-to-treat-multiple-sclerosis/ 2020-02-28T11:22:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/emcyte-announces-fda-510k-clearance-for-its-pureprp-supraphysiologic-concentrating-system/ 2020-02-28T11:27:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/twinstrand-biosciences-launches-duplex-sequencing-technology/ 2020-02-28T11:32:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/TwinStrand-Logo.png http://www.pharmajournalist.com/biogen-and-sangamo-announce-global-collaboration-to-develop-gene-regulation-therapies/ 2020-02-28T11:34:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/zpredicta-enters-strategic-collaboration-with-labcorp-to-advance-the-use-of-3d-cell-cultures-in-rd-development/ 2020-02-28T11:38:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/zPREDICTA-Logo.jpg http://www.pharmajournalist.com/pandion-announces-first-subject-dosed-in-a-phase-1-clinical-trial-of-pt101-an-il-2-mutein-fc-fusion-therapy-for-autoimmune-disease/ 2020-02-28T11:44:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pandion-therapeutics-logo.png http://www.pharmajournalist.com/takeda-acquires-pvp-biologics-following-results-of-a-phase-1-study-of-tak-062-kuma062-for-the-treatment-of-celiac-disease-2/ 2020-02-28T11:47:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/lysogene-receives-fda-fast-track-designation-for-lys-saf302-gene-therapy-in-mps-iiia/ 2020-02-28T11:50:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lysogene-logo.jpg http://www.pharmajournalist.com/altasciences-adds-comprehensive-contract-manufacturing-and-analytical-services-to-its-early-phase-research-offering/ 2020-02-28T11:57:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/AltaSciences-Logo.jpg http://www.pharmajournalist.com/pharmaceutics-international-pii-expands-aseptic-filling-capabilities-with-fully-robotic-filling-line/ 2020-02-28T12:01:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Pii-Logo.jpg http://www.pharmajournalist.com/perrigo-and-catalent-announce-fda-approval-of-perrigos-ab-rated-generic-version-of-proair-hfa/ 2020-02-28T12:14:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/perrigo-logo.jpg http://www.pharmajournalist.com/immunos-therapeutics-selects-probiogen-for-development-and-large-scale-manufacturing-services/ 2020-02-28T12:19:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Immunos-Therapeutics-Logo.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-stephen-hunt-professor-at-ucl-released-ahead-of-pain-therapeutics-2020/ 2020-02-28T12:30:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-2020-Pharma-Journalist.jpg http://www.pharmajournalist.com/what-to-expect-for-smis-ai-in-drug-discovery-conference-2-weeks-to-go/ 2020-03-03T10:10:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/AI-Drug-Discovery.jpg http://www.pharmajournalist.com/qa-with-skan-ag-speaker-released-for-highly-potent-active-pharmaceutical-ingredients-2020/ 2020-03-04T08:18:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/300X250-copy.jpg http://www.pharmajournalist.com/arcturus-and-duke-nus-medical-school-partner-to-develop-a-coronavirus-covid-19-vaccine-using-starr-technology/ 2020-03-06T10:24:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Arcturus-Therapeutics.jpg http://www.pharmajournalist.com/amunix-raises-73-million-in-series-a-financing-led-by-omega-funds/ 2020-03-06T10:30:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Amunix-Logo.png http://www.pharmajournalist.com/heat-biologics-launches-program-to-develop-vaccine-designed-to-protect-against-covid-19-coronavirus/ 2020-03-06T10:33:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Heat-Biologics-Logo.jpg http://www.pharmajournalist.com/vir-and-alnylam-expand-collaboration-to-advance-rnai-therapeutics-for-the-treatment-of-coronavirus-infection-including-covid-19/ 2020-03-06T10:34:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/takeda-initiates-development-of-a-plasma-derived-therapy-for-covid-19/ 2020-03-06T10:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-device-designation-for-roches-elecsys-galad-score-to-support-earlier-diagnosis-of-hcc/ 2020-03-06T10:40:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/lilly-statement-on-novel-coronavirus-and-the-reliable-supply-of-the-companys-medicines/ 2020-03-06T10:43:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/inovio-accelerates-timeline-for-covid-19-dna-vaccine-ino-4800/ 2020-03-06T10:45:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-genentechs-esbriet-pirfenidone-in-uild/ 2020-03-06T10:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Genentech-Logo.jpg http://www.pharmajournalist.com/mateon-provides-update-on-its-rapid-antiviral-response-program-initially-targeting-covid-19/ 2020-03-06T10:56:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/MATEON-Therapeutics-Logo.jpg http://www.pharmajournalist.com/gilead-to-acquire-forty-seven-for-4-9-billion/ 2020-03-06T11:00:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/astrazeneca-completes-divestment-agreement-with-atnahs-pharma-for-established-hypertension-medicines/ 2020-03-06T11:03:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/takeda-agrees-to-divest-select-otc-and-non-core-assets-in-latin-america-to-hypera-pharma/ 2020-03-06T11:07:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/samsung-biologics-and-stcube-enter-into-development-and-manufacturing-agreement-for-novel-target-anticancer-drug/ 2020-03-06T11:09:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Samsung-BioLogics.jpg http://www.pharmajournalist.com/cytoo-and-askbio-enter-research-agreement-to-screen-gene-therapy-candidates-for-rare-muscle-disorder/ 2020-03-06T11:14:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/AskBio-Logo.jpe http://www.pharmajournalist.com/acadia-and-neuren-announce-rare-pediatric-disease-designation-for-trofinetide-for-the-treatment-of-rett-syndrome/ 2020-03-06T11:16:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/ACADIA-Pharma-Logo.jpg http://www.pharmajournalist.com/biocryst-begins-proof-of-concept-trial-in-pnh-patients-with-oral-factor-d-inhibitor-bcx9930/ 2020-03-06T11:29:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/biocryst-logo.jpg http://www.pharmajournalist.com/nexelis-to-acquire-specialty-immunogenicity-and-immune-oncology-testing-laboratory-immunxperts/ 2020-03-06T11:32:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/nexelis-logo.jpg http://www.pharmajournalist.com/amag-pharmaceuticals-announces-changes-to-medical-development-organization/ 2020-03-06T11:37:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Amag-Pharma.jpg http://www.pharmajournalist.com/milliporesigmas-new-lanexo-system-to-improve-scientists-productivity-in-the-lab/ 2020-03-06T11:41:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/MilliporeSigmas-new-LANEXO-System.jpg https://pharmajournalist.com/wp-content/uploads/2020/03/MilliporeSigmas-new-LANEXO-System.jpg http://www.pharmajournalist.com/mimetas-to-launch-assay-ready-product-line-for-organ-on-a-chip/ 2020-03-06T11:45:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/MIMETAS-Organ-on-a-Chip.png http://www.pharmajournalist.com/completion-of-study-enrolment-of-implandatas-extraocular-eye-pressure-sensor-for-continual-glaucoma-monitoring/ 2020-03-06T11:50:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Implandata-Ophthalmic-Products.jpg http://www.pharmajournalist.com/urovant-sciences-announces-fda-acceptance-of-new-drug-application-for-vibegron-for-the-treatment-of-overactive-bladder/ 2020-03-06T12:27:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/UROVANT-Sciences-Logo.jpg http://www.pharmajournalist.com/cellectis-and-servier-execute-the-amendment-confirming-the-expansion-of-their-collaboration-on-ucart19-products/ 2020-03-06T12:28:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Cellectis-Logo.png http://www.pharmajournalist.com/speaker-spotlight-advancing-inhalation-drug-delivery/ 2020-03-06T17:32:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/SUSAN-HOE.png https://pharmajournalist.com/wp-content/uploads/2020/03/SUSAN-HOE.png http://www.pharmajournalist.com/interview-with-martin-everett-speaker-at-smis-superbugs-superdrugs-conference/ 2020-03-10T08:40:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Superbugs-Superdrugs-2020.jpg http://www.pharmajournalist.com/interactive-pre-conference-workshop-announced-for-injectable-drug-delivery-2020/ 2020-03-11T09:02:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Injectable-drug-delivery.jpg http://www.pharmajournalist.com/fda-added-to-innovative-el-usa-2020-program/ 2020-03-11T10:57:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/EL-USA-2020-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/vir-biotechnology-announces-intent-to-collaborate-with-biogen-on-manufacturing-of-antibodies-to-potentially-treat-covid-19/ 2020-03-13T08:42:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/emergent-biosolutions-initiates-development-of-plasma-derived-product-candidates-for-the-treatment-and-prevention-of-coronavirus-disease/ 2020-03-13T08:45:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/emergent-biosolutions_logo.jpg http://www.pharmajournalist.com/bms-gets-fda-approval-for-opdivo-plus-yervoy-to-treat-hcc/ 2020-03-13T08:49:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/around-10000-people-could-benefit-from-new-migraine-drug-as-nice-says-its-cost-effective/ 2020-03-13T08:52:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/woman-in-pain.jpg https://pharmajournalist.com/wp-content/uploads/2020/03/woman-in-pain.jpg http://www.pharmajournalist.com/bill-melinda-gates-foundation-wellcome-and-mastercard-launch-initiative-to-speed-development-and-access-to-therapies-for-covid-19/ 2020-03-13T08:57:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Covid-19.jpg http://www.pharmajournalist.com/cel-sci-initiates-development-of-immunotherapy-to-treat-covid-19-coronavirus-infection/ 2020-03-13T09:04:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/CEL-SCI-Logo.jpg http://www.pharmajournalist.com/novavax-awarded-funding-from-cepi-for-covid-19-vaccine-development/ 2020-03-13T09:17:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/viiv-healthcare-unc-chapel-hill-announce-five-year-20-million-renewal-of-hiv-cure-partnership/ 2020-03-13T09:20:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/David-Margolis.jpeg https://pharmajournalist.com/wp-content/uploads/2020/03/David-Margolis.jpeg http://www.pharmajournalist.com/harbour-biomed-raises-75-million-series-b-venture-capital-financing-to-accelerate-its-innovative-pipeline/ 2020-03-13T09:24:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/abbvie-partnering-with-global-authorities-to-determine-efficacy-of-hiv-drug-in-treating-covid-19/ 2020-03-13T09:27:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/nanoform-and-orion-collaborate-on-next-generation-drug-development/ 2020-03-13T09:31:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/nanoform-logo.png http://www.pharmajournalist.com/zydus-and-xoma-announce-il-2-based-immuno-oncology-therapy-licensing-agreement/ 2020-03-13T09:33:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/xoma-logo.png http://www.pharmajournalist.com/phio-and-helmholtz-zentrum-munchen-announce-collaboration-and-option-agreement-with-medigene/ 2020-03-13T10:13:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Phio-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/abcellera-and-lilly-to-co-develop-antibody-therapies-for-the-treatment-of-covid-19/ 2020-03-13T10:15:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/tyligand-bioscience-and-context-therapeutics-sign-strategic-development-agreement-for-onapristone-er/ 2020-03-13T10:18:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/context-therapeutics-logo.png http://www.pharmajournalist.com/kuur-therapeutics-launches-to-develop-and-commercialise-off-the-shelf-car-nkt-cell-therapies/ 2020-03-13T10:26:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Kuur-therapeutics-logo.jpg http://www.pharmajournalist.com/inmed-pharmaceuticals-announces-completed-enrollment-in-phase-1-clinical-trial-of-inm-755-cbn-cream-in-healthy-subjects/ 2020-03-13T10:31:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/inmed-pharma-logo.jpg http://www.pharmajournalist.com/nagase-nagase-medicals-and-osaka-university-launch-joint-research-program/ 2020-03-13T11:31:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Nagase-Logo-1.jpg http://www.pharmajournalist.com/fujifilm-diosynth-biotechnologies-breaks-ground-on-a-new-biocampus-at-its-billingham-uk-location/ 2020-03-13T11:46:01+00:00 http://www.pharmajournalist.com/wp-content/uploads/2020/03/FUJIFILM-Diosynth.jpg http://www.pharmajournalist.com/eurofins-scientific-supports-sars-cov-2-analyses-needs-in-the-u-s-a-and-in-europe-with-multiple-testing-options/ 2020-03-13T11:57:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/chime-biologics-evolving-into-one-of-the-leading-cdmos-in-china-serving-the-global-biotech-industry/ 2020-03-13T11:58:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-signs-agreement-with-janssen-to-co-develop-companion-diagnostic-for-cancer/ 2020-03-13T12:05:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/fda-inks-research-collaboration-agreement-with-anabios-focused-on-human-primary-cardiomyocytes/ 2020-03-13T12:08:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/windmil-and-cognate-announce-agreement-to-expand-mils-manufacturing-capacity/ 2020-03-13T12:11:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/WindMIL-Therapeutics.png http://www.pharmajournalist.com/chair-interview-with-justin-mason-home-released-for-highly-potent-active-pharmaceutical-ingredients-2020/ 2020-03-18T08:11:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/300X250-copy.jpg http://www.pharmajournalist.com/imfinzi-delivers-sustained-overall-survival-benefit-in-final-analysis-of-caspian-trial/ 2020-03-19T15:13:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/merck-announces-top-line-results-from-phase-3-trials-evaluating-gefapixant/ 2020-03-19T15:14:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/pfizer-and-biontech-to-co-develop-potential-covid-19-vaccine/ 2020-03-19T15:16:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/moderna-announces-first-participant-dosed-in-nih-led-phase-1-study-of-mrna-vaccine-mrna-1273-against-novel-coronavirus/ 2020-03-19T15:19:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/aurinia-initiates-rolling-submission-of-a-nda-to-fda-for-voclosporin-in-the-treatment-of-lupus-nephritis/ 2020-03-19T15:23:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Aurinia-Pharma-Logo.jpg http://www.pharmajournalist.com/acelrx-pharmaceuticals-to-acquire-tetraphase-pharmaceuticals/ 2020-03-19T15:25:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AcelRx-Pharma-logo.jpg http://www.pharmajournalist.com/lilly-receives-fda-breakthrough-therapy-designation-for-baricitinib-for-the-treatment-of-alopecia-areata/ 2020-03-19T15:28:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/biostem-life-sciences-announces-expansion-contract-manufacturing-capabilities-and-rd-laboratory/ 2020-03-19T15:30:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/BioStem-Logo.jpg http://www.pharmajournalist.com/imv-inc-launches-plans-to-advance-clinical-development-of-a-vaccine-candidate-against-covid-19/ 2020-03-19T15:34:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/IMV-Logo.png http://www.pharmajournalist.com/roche-initiates-phase-iii-clinical-trial-of-actemra-roactemra-in-hospitalised-patients-with-severe-covid-19-pneumonia/ 2020-03-19T15:40:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/emergent-biosolutions-and-vaxart-partner-on-oral-coronavirus-vaccine/ 2020-03-19T15:42:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/novartis-receives-approval-from-japanese-mhlw-for-zolgensma/ 2020-03-19T15:45:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/regeneron-announces-important-advances-in-novel-covid-19-antibody-program/ 2020-03-19T15:48:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/regeneron-and-sanofi-begin-global-kevzara-sarilumab-clinical-trial-program-in-patients-with-severe-covid-19/ 2020-03-19T15:49:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/ose-immunotherapeutics-updates-licensing-deal-with-servier/ 2020-03-19T15:51:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/OSE-Immunotherapeutics-Logo.jpg http://www.pharmajournalist.com/xortx-launches-xrx-101-a-new-program-to-treat-coronavirus-covid-19-infection/ 2020-03-19T15:55:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/XORTX_Therapeutics-Logo.jpg http://www.pharmajournalist.com/celltex-plans-to-launch-program-to-use-mesenchymal-stem-cells-for-covid-19-related-symptoms-under-an-existing-regulatory-study/ 2020-03-19T15:57:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Celltex_Lab.jpg http://www.pharmajournalist.com/emd-serono-and-pfizer-provide-update-on-phase-iii-javelin-head-and-neck-100-study/ 2020-03-20T13:37:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/beijing-tide-pharmaceutical-and-insilico-medicine-enter-into-a-strategic-partnership-agreement-for-cancer-therapy/ 2020-03-20T13:40:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Beijing-Tide-Insilico.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/03/Beijing-Tide-Insilico.jpg http://www.pharmajournalist.com/askbio-enters-research-collaboration-and-licensing-agreement-with-unc-for-angelman-syndrome/ 2020-03-20T13:47:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/AskBio-Logo.jpe http://www.pharmajournalist.com/dragonfly-therapeutics-announces-multi-target-expansion-of-its-collaboration-with-merck/ 2020-03-20T13:51:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dragonfly-Therapeutics-logo.png http://www.pharmajournalist.com/ridgeback-biotherapeutics-and-drive-partner-to-develop-clinical-stage-coronavirus-treatment/ 2020-03-20T13:54:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Covid-19.jpg http://www.pharmajournalist.com/roosterbio-partners-with-senti-biosciences-to-rapidly-translate-gene-circuit-cell-therapy-into-the-clinic/ 2020-03-23T13:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/chair-invite-from-kerrie-brady-michael-scherz-released-ahead-of-pain-therapeutics-conference/ 2020-03-23T14:39:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics_Pharma-Journalist_Remote-Access.jpg http://www.pharmajournalist.com/qa-with-team-consulting-ltd-released-for-injectable-drug-delivery-2020/ 2020-03-24T12:19:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Injectable-Drug-Delivery_Pharma-Journalist.jpg http://www.pharmajournalist.com/1-week-to-go-to-smis-22nd-annual-superbugs-superdrugs-conference/ 2020-03-24T12:45:12+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Superbugs-Superdrugs_PJ_Remote-Access.jpg http://www.pharmajournalist.com/speaker-interview-with-krystin-meidell-from-biogen-ahead-of-pre-filled-syringes-east-coast-2020/ 2020-03-25T10:18:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-EC.jpg http://www.pharmajournalist.com/sorrento-launches-novel-i-cell-covid-19-cellular-vaccine-program/ 2020-03-27T03:54:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/astrazenecas-lokelma-approved-in-japan-for-the-treatment-of-hyperkalaemia/ 2020-03-27T03:57:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/xencor-and-vir-biotechnology-enter-license-agreement-for-covid-19/ 2020-03-27T04:01:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/grifols-announces-formal-collaboration-with-us-government-to-produce-the-first-treatment-specifically-targeting-covid-19/ 2020-03-27T04:06:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Grifols.jpg http://www.pharmajournalist.com/astrazeneca-and-silence-therapeutics-sign-drug-development-deal/ 2020-03-27T04:09:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/novavax-nanoflu-achieves-all-primary-endpoints-in-phase-3-clinical-trial/ 2020-03-27T04:11:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/soligenix-and-university-of-hawai%ca%bbi-at-manoa-initiate-work-on-novel-coronavirus-vaccine-for-covid-19/ 2020-03-27T04:15:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/soligenix-logo.jpg http://www.pharmajournalist.com/genentech-announces-fda-approval-of-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/ 2020-03-27T04:17:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Genentech-Building.jpeg http://www.pharmajournalist.com/genentech-announces-venclexta-combination-improved-overall-survival-in-people-with-previously-untreated-acute-myeloid-leukemia/ 2020-03-27T04:20:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/takeda-receives-approval-of-entyvio-vedolizumab-in-china/ 2020-03-27T04:21:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/bayer-and-curadev-sign-research-collaboration-and-license-agreement/ 2020-03-27T04:24:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/junshi-biosciences-signed-co-development-agreement-with-imcas-to-advance-nab-for-covid-19-treatment/ 2020-03-27T04:28:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Junshi-Biosciences.png http://www.pharmajournalist.com/tarveda-therapeutics-and-sciclone-pharmaceuticals-international-establish-licensing-agreement-for-pen-866-in-greater-china/ 2020-03-27T04:33:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Tarveda-Therapeutics-logo.png http://www.pharmajournalist.com/fda-provides-update-on-patient-access-to-certain-rems-drugs-during-covid-19-public-health-emergency/ 2020-03-27T04:34:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/flexipharm-austrading-announces-product-update-on-arsenic-trioxide-phebra/ 2020-03-27T04:37:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Flexipharm-Austrading.png http://www.pharmajournalist.com/cytomx-therapeutics-and-astellas-announce-strategic-collaboration-to-develop-probody-t-cell-engaging-bispecific-therapies-for-treatment-of-cancer/ 2020-03-27T04:40:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/sorrento-and-smartpharm-to-collaborate-to-develop-novel-gene-encoded-antibody-vaccine-intended-to-protect-against-covid-19/ 2020-03-27T04:42:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/forge-enters-into-collaboration-with-roche-to-develop-novel-antibiotic-to-treat-lung-infections/ 2020-03-27T04:43:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Forge-Therapeutics-Logo.jpg http://www.pharmajournalist.com/infinity-gets-fda-fast-track-designation-for-ipi-549-opdivo-combo-in-urothelial-cancer/ 2020-03-27T04:47:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Infinity-Pharma-Logo.jpg http://www.pharmajournalist.com/hoth-therapeutics-announces-agreement-to-joint-development-for-a-sav-for-the-potential-prevention-of-coronavirus/ 2020-03-27T04:51:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Hoth-Therapeutics-Logo.jpg http://www.pharmajournalist.com/abbvie-announces-positive-topline-results-from-phase-3-trial-of-venclexta-azacitidine-combo-in-aml/ 2020-03-27T04:54:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/alvotech-and-dksh-partner-to-bring-key-biosimilar-to-asia/ 2020-03-27T04:59:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/alvotech-facility.jpg http://www.pharmajournalist.com/debiopharm-expands-its-radiopharmaceutical-footprint/ 2020-03-27T05:02:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Debiopharm-Logo.png http://www.pharmajournalist.com/sartorius-supports-the-development-of-the-first-vaccine-candidate-against-the-novel-coronavirus-to-enter-clinical-trials/ 2020-03-27T05:05:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Coronavirus.png http://www.pharmajournalist.com/immunogenesis-contracts-probiogen-for-development-and-large-scale-manufacturing-services/ 2020-03-27T05:15:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/vaccitech-and-oxford-university-announce-promising-phase-2a-data-on-prostate-cancer-immunotherapy/ 2020-03-27T05:17:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Vaccitech-Logo.png http://www.pharmajournalist.com/registration-is-open-for-pharmaceutical-microbiology-west-coast-2021/ 2020-03-30T08:41:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Pharma-Micro-WC-2021.jpg http://www.pharmajournalist.com/exclusive-allergan-speaker-interview-released-for-pre-filled-syringes-west-coast-conference-2021/ 2020-03-30T12:28:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/chair-letter-released-for-the-pre-filled-syringes-west-coast-conference-in-june/ 2020-03-30T12:33:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/post-conference-workshop-day-announced-for-pre-filled-syringes-west-coast-2021/ 2020-03-30T12:34:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/registration-opens-for-pre-filled-syringes-west-coast-2021/ 2020-03-30T12:38:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-WC-2021.jpg http://www.pharmajournalist.com/kite-licenses-antibodies-and-establishes-collaboration-with-teneobio-in-multiple-myeloma/ 2020-04-03T06:39:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Kite-Pharma.jpg http://www.pharmajournalist.com/novartis-announces-mutual-agreement-to-terminate-sale-of-sandoz-us-generic-oral-solids-dermatology-portfolio-to-aurobindo/ 2020-04-03T06:41:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-announces-plan-to-initiate-clinical-study-of-jakavi-in-severe-covid-19-patients-and-establish-international-compassionate-use-program/ 2020-04-03T06:42:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/immunitybio-combines-supercomputing-power-with-microsoft-azure-to-target-infection-doorway-of-the-coronavirus/ 2020-04-03T06:46:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/sorrento-to-provide-manufacturing-support-to-celularity-as-cynk-001-trial-for-covid-19-begins-enrolling-patients/ 2020-04-03T06:50:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/sorrento-enters-preclinical-testing-agreement-for-covid-19-candidates/ 2020-04-03T06:52:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/vbi-vaccines-announces-tie-up-to-develop-pan-coronavirus-vaccine-candidate-targeting-covid-19-sars-and-mers/ 2020-04-03T06:55:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/VBI-Vaccines-Logo.jpg http://www.pharmajournalist.com/neurimmune-and-ethris-collaborate-to-rapidly-develop-inhaled-mrna-based-antibody-therapy-for-the-treatment-of-covid-19/ 2020-04-03T06:57:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/neurimmune-image.jpg http://www.pharmajournalist.com/cobra-biologics-and-the-karolinska-institutet-collaborate-to-develop-covid-19-vaccine/ 2020-04-03T07:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Cobra-Biologics-image.jpg http://www.pharmajournalist.com/aptorum-group-and-covar-pharmaceuticals-explore-repurposed-drugs-for-coronavirus/ 2020-04-03T07:03:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/aptorum_logo.jpg http://www.pharmajournalist.com/gigagen-initiates-development-of-recombinant-polyclonal-antibody-therapy-for-covid-19/ 2020-04-03T07:06:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/GigaGen-Logo.jpg http://www.pharmajournalist.com/noveome-launches-program-to-evaluate-st266-for-the-treatment-of-the-severe-inflammatory-response-associated-with-covid-19/ 2020-04-03T07:09:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Noveome-Bio-Logo.png http://www.pharmajournalist.com/altimmune-and-the-university-of-alabama-at-birmingham-to-collaborate-on-development-of-single-dose-intranasal-covid-19-vaccine/ 2020-04-03T07:13:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/altimmune_logo.png http://www.pharmajournalist.com/astrazeneca-divestment-of-movantik-to-redhill-biopharma-completed/ 2020-04-03T07:15:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazenecas-lokelma-recommended-for-approval-in-eu-for-patients-with-hyperkalaemia-on-stable-haemodialysis/ 2020-04-03T07:17:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazenecas-imfinzi-approved-in-the-us-for-extensive-stage-small-cell-lung-cancer/ 2020-04-03T07:19:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ryvu-therapeutics-receives-orphan-drug-designation-from-fda-for-sel120-to-treat-acute-myeloid-leukemia/ 2020-04-03T07:22:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/imaginab-announces-licensing-deal-with-astrazeneca-for-cd8-immunopet-technology/ 2020-04-03T07:25:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImaginAb-Logo.jpg http://www.pharmajournalist.com/ostrich-pharma-usa-produces-antibodies-to-block-the-virus-that-causes-covid-19/ 2020-04-03T07:31:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/agilent-introduces-new-handheld-raw-material-id-system-for-pharmaceutical-manufacturers/ 2020-04-03T07:34:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agilent-logo.png http://www.pharmajournalist.com/lilly-and-sitryx-announce-licensing-and-research-collaboration-to-discover-and-develop-new-immunometabolic-medicines/ 2020-04-03T07:35:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/citius-signs-exclusive-option-with-novellus-to-license-novel-stem-cell-therapy-for-ards-associated-with-covid-19/ 2020-04-03T07:38:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/citiuspharma-logo.png http://www.pharmajournalist.com/fate-therapeutics-announces-worldwide-collaboration-with-janssen-for-novel-ipsc-derived-cell-based-cancer-immunotherapies/ 2020-04-03T07:39:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Fate-Therapeutics-Logo.jpg http://www.pharmajournalist.com/bristol-myers-squibb-and-bluebird-bio-submit-bla-for-idecabtagene-vicleucel-to-fda/ 2020-04-03T07:42:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/due-to-covid-19-pain-therapeutics-conference-will-be-accessed-remotely/ 2020-04-03T07:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics_Pharma-Journalist_Remote-Access.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics_Pharma-Journalist_Remote-Access.jpg http://www.pharmajournalist.com/arena-international-announces-the-inaugural-temperature-controlled-logistics-in-biopharmaceuticals-virtual-experience-conference/ 2020-04-03T10:35:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/TCLUS-300X250-virtual.png http://www.pharmajournalist.com/novartis-to-speak-at-smi-groups-injectable-drug-delivery-2020/ 2020-04-07T09:37:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Injectable-Drug-Delivery_Pharma-Journalist.jpg http://www.pharmajournalist.com/associates-of-cape-cod-webinar-on-recombinant-chromogenic-assay-as-alternate-methods-for-the-bacterial-endotoxins-test-announced/ 2020-04-07T15:03:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Free-Webinar-SMi-Group.jpg http://www.pharmajournalist.com/eyeforpharma-a-division-of-reuters-events-announces-eyeforpharma-philadelphia-2020-is-now-a-virtual-event/ 2020-04-08T08:34:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/eyeforpharma-banner.png http://www.pharmajournalist.com/gilead-and-second-genome-announce-strategic-collaboration-in-biomarker-and-ibd-drug-discovery/ 2020-04-08T08:49:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/gilead-completes-acquisition-of-forty-seven-inc/ 2020-04-08T08:51:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/global-plasma-leaders-collaborate-to-accelerate-development-of-potential-covid-19-hyperimmune-therapy/ 2020-04-08T08:53:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/ec-approves-takedas-alunbri-brigatinib-as-a-first-line-treatment-for-alk-nsclc/ 2020-04-08T08:54:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/gsk-and-vir-biotechnology-enter-collaboration-to-find-coronavirus-solutions/ 2020-04-08T08:56:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/xbiotech-and-biobridge-to-develop-potential-covid-19-treatment-based-on-natural-antibodies-from-recovered-patients/ 2020-04-08T08:58:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/Xbiotech-1.jpg http://www.pharmajournalist.com/servier-signed-a-definitive-agreement-to-acquire-symphogen/ 2020-04-08T09:00:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Servier-CDMO.png http://www.pharmajournalist.com/csl-behring-and-sab-biotherapeutics-join-forces-to-deliver-new-potential-covid-19-therapeutic/ 2020-04-09T09:58:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CSL-Behring.png http://www.pharmajournalist.com/hitgen-and-mtpc-enter-into-license-agreement/ 2020-04-09T10:01:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/acceleron-receives-fda-breakthrough-therapy-designation-for-sotatercept-in-pulmonary-arterial-hypertension/ 2020-04-10T10:14:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Accleron-Pharma.jpg http://www.pharmajournalist.com/cromsource-announces-launch-of-covid-19-clinical-trial/ 2020-04-10T10:18:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CROMSOURCE-Logo.jpg http://www.pharmajournalist.com/neoimmunetech-announces-clinical-collaboration-with-bristol-myers-squibb/ 2020-04-10T10:24:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/12/NeoImmuneTech-Logo-1.jpg http://www.pharmajournalist.com/pfizer-and-biontech-announce-further-details-on-collaboration-to-accelerate-global-covid-19-vaccine-development/ 2020-04-10T10:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/oncoimmune-receives-fda-approval-for-covid-19-clinical-trial/ 2020-04-10T10:29:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/OncoImmune-Logo.jpg http://www.pharmajournalist.com/cytovia-and-macromoltek-to-develop-dual-acting-natural-killer-immunotherapy-against-sars-cov2-covid-19/ 2020-04-10T10:32:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CYTOVIA-Therapeutics-Logo.png http://www.pharmajournalist.com/arrakis-therapeutics-enters-strategic-collaboration-and-license-agreement-with-roche-for-multi-target-program-utilizing-rna-targeted-small-molecule-drug-discovery-platform/ 2020-04-10T10:39:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Arrakis_Logo.jpg http://www.pharmajournalist.com/oxford-biomedica-joins-consortium-to-rapidly-develop-a-covid-19-vaccine-candidate/ 2020-04-10T10:42:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg http://www.pharmajournalist.com/avacta-and-cytiva-collaborating-on-covid-19-rapid-test/ 2020-04-10T10:50:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Avacta.jpg http://www.pharmajournalist.com/roche-provides-regulatory-update-on-risdiplam-for-the-treatment-of-spinal-muscular-atrophy-sma/ 2020-04-10T10:54:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/regeneron-and-zai-lab-announce-regional-strategic-collaboration-for-regn1979/ 2020-04-10T10:57:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/recipharms-proprietary-molecule-erdosteine-to-be-tested-as-part-of-covid-19-treatment/ 2020-04-10T10:59:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/cambrex-completes-biopharmaceutical-expansion-at-its-durham-nc-facility/ 2020-04-10T11:01:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/registration-is-now-open-for-smi-groups-pre-filled-syringes-san-francisco/ 2020-04-15T10:41:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/registration-is-now-open-for-oligonucleotide-therapeutics-and-delivery-2020/ 2020-04-16T11:01:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide.jpg http://www.pharmajournalist.com/arena-international-announces-the-virtual-experience-of-clinical-trial-supply-conference-series/ 2020-04-16T11:31:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CTSWC-300X250-virtual.png http://www.pharmajournalist.com/arena-international-announces-the-leading-outsourcing-in-clinical-trials-conference-as-a-virtual-experience/ 2020-04-16T11:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/OCT-virtual-banner-300x250-1.png http://www.pharmajournalist.com/tscan-and-novartis-partner-to-develop-cancer-therapies/ 2020-04-17T11:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/fujifilm-accelerates-production-of-its-influenza-antiviral-drug-avigan-tablet-for-covid-19/ 2020-04-17T11:12:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/applied-dna-ships-covid-19-lineardna-vaccine-candidates-to-italian-development-partner-to-begin-preclinical-animal-testing/ 2020-04-17T11:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/applieddna_logo.jpg http://www.pharmajournalist.com/insilico-and-boehringer-to-apply-novel-generative-ai-for-discovery-of-potential-therapeutic-targets/ 2020-04-17T11:20:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Insilico-Boehringer.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/04/Insilico-Boehringer.jpg http://www.pharmajournalist.com/nantkwest-and-immunitybio-announce-therapeutics-and-vaccines-for-combatting-covid-19/ 2020-04-17T11:25:10+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/NantKwest-Logo.jpg http://www.pharmajournalist.com/sanofi-and-gsk-to-join-forces-in-unprecedented-vaccine-collaboration-to-fight-covid-19/ 2020-04-17T11:29:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/blackstone-and-alnylam-enter-into-2-billion-strategic-financing-collaboration-to-accelerate-the-advancement-of-rnai-therapeutics/ 2020-04-17T11:32:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/astrazeneca-initiates-calavi-clinical-trial-with-calquence-against-covid-19/ 2020-04-17T11:34:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/celltrion-completes-neutralization-test-on-candidate-mabs-for-covid-19-antiviral-antibody-treatment/ 2020-04-17T11:36:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/pharmajet-partners-with-immunomic-therapeutics-and-epivax-to-develop-and-deliver-covid-19-vaccine/ 2020-04-17T11:38:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Needle-Free-Injection-Pharmajet.png http://www.pharmajournalist.com/koselugo-selumetinib-approved-in-us-for-paediatric-patients-with-neurofibromatosis-type-1-plexiform-neurofibromas/ 2020-04-17T11:41:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/vir-2218-demonstrates-dose-dependent-and-durable-reductions-of-hepatitis-b-surface-antigen-in-phase-1-2-trial/ 2020-04-17T11:47:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/VIR-Logo.jpg http://www.pharmajournalist.com/merck-announces-us-launch-of-ontruzant-trastuzumab-dttb-a-biosimilar-of-herceptin-trastuzumab/ 2020-04-17T11:51:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/forma-therapeutics-receives-fda-orphan-drug-designation-for-ft-4202-for-the-treatment-of-sickle-cell-disease/ 2020-04-17T11:53:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/sinovac-announces-approval-of-human-clinical-trial-for-a-vaccine-candidate-against-covid-19/ 2020-04-17T11:55:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/intensity-therapeutics-signs-clinical-collaboration-agreement-with-bms-for-advanced-solid-tumors/ 2020-04-17T11:57:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/hope-biosciences-receives-second-fda-clearance-for-a-phase-ii-clinical-trial-for-protection-against-covid-19/ 2020-04-17T13:17:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Hope_Logo.jpg http://www.pharmajournalist.com/ridgeback-bio-announces-mhra-clearance-to-begin-human-testing-of-eidd-2801-for-covid-19/ 2020-04-17T13:19:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/ascletis-receives-ind-approval-for-its-hiv-drug-asc09f/ 2020-04-17T13:21:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ascletis-logo.jpg http://www.pharmajournalist.com/fda-approves-first-therapy-for-children-with-debilitating-and-disfiguring-rare-disease/ 2020-04-17T13:23:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immunoprecise-announces-agreement-with-janssen/ 2020-04-17T13:25:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunoPrecise-Logo.jpg http://www.pharmajournalist.com/soligenix-announces-exclusive-licensing-agreement-for-novel-vaccine-adjuvant-from-btg-specialty-pharma/ 2020-04-17T13:27:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/soligenix-logo.jpg http://www.pharmajournalist.com/synthon-biopharmaceuticals-relaunches-as-byondis/ 2020-04-17T13:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/byondis-logo.jpg http://www.pharmajournalist.com/extractables-and-leachables-usa-2020-has-been-postponed-to-october/ 2020-04-17T13:33:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/EL-USA-2020-date-change.jpg http://www.pharmajournalist.com/halix-enters-collaboration-with-the-university-of-oxford-for-gmp-manufacturing-of-a-covid-19-vaccine/ 2020-04-17T13:35:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Halix-Building.jpg http://www.pharmajournalist.com/covid-19-update-highly-potent-active-pharmaceutical-ingredients-2020-now-remote-access-only/ 2020-04-20T10:30:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/HPAPI_PJ_Remote-Access.jpg http://www.pharmajournalist.com/chair-letter-released-for-smi-groups-pre-filled-syringes-san-francisco-2020/ 2020-04-21T12:08:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/gilead-kite-and-onko-innate-announce-research-collaboration-to-discover-cancer-immunotherapies-focused-on-nk-cells/ 2020-04-24T07:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/griffith-university-researchers-on-the-road-to-covid-19-vaccine/ 2020-04-24T07:09:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Griffith-University.jpg http://www.pharmajournalist.com/mits-love-lab-developing-a-covid-19-vaccine-to-potentially-reach-billions/ 2020-04-24T07:15:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/novartis-kymriah-receives-fda-regenerative-medicine-advanced-therapy-designation-in-follicular-lymphoma/ 2020-04-24T07:17:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/som-biotech-announces-in-vitro-confirmation-of-three-drug-candidates-for-covid-19/ 2020-04-24T07:20:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/vaccine.jpg http://www.pharmajournalist.com/redhill-biopharma-announces-agreement-with-niaid-to-evaluate-rhb-107-against-covid-19/ 2020-04-24T07:22:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/fda-and-ema-accept-applications-for-roches-ocrevus-ocrelizumab-shorter-2-hour-infusion-time/ 2020-04-24T07:25:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/novartis-announces-data-showing-jakavi-more-effective-than-best-available-therapy-in-acute-gvhd/ 2020-04-24T07:29:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-says-new-mayzent-data-shows-sustained-effect-in-delaying-disability/ 2020-04-24T07:32:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-to-sponsor-large-clinical-trial-of-hydroxychloroquine-in-hospitalized-covid-19-patients/ 2020-04-24T07:34:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/incyte-announces-initiation-of-phase-3-trial-of-ruxcovid-to-treat-covid-19/ 2020-04-24T07:39:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/hope-biosciences-announces-third-fda-approved-clinical-trial-for-covid-19/ 2020-04-24T07:42:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Hope_Logo.jpg http://www.pharmajournalist.com/nexus-pharmaceuticals-announces-approval-of-emerphed-injection/ 2020-04-24T07:44:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Emerphed-v1.jpg https://pharmajournalist.com/wp-content/uploads/2020/04/Emerphed-v1.jpg http://www.pharmajournalist.com/european-commission-approves-nintedanib-for-the-treatment-of-ssc-ild/ 2020-04-24T07:47:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/wavelength-pharmaceuticals-expands-supplies-of-key-drug-ingredients-for-critically-ill-covid-19-patients/ 2020-04-24T07:49:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/wavelength-logo.jpg http://www.pharmajournalist.com/alexion-announces-plans-to-initiate-phase-3-study-of-ultomiris-in-hospitalized-patients-with-severe-covid-19/ 2020-04-24T07:50:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/fosun-pharma-receives-fda-emergency-use-authorization-eua-for-its-covid-19-rt-pcr-detection-kit/ 2020-04-24T07:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Fosun-Pharma.jpg http://www.pharmajournalist.com/amblyotech-a-digital-therapeutics-company-announces-it-has-been-acquired-by-novartis/ 2020-04-24T07:58:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Amblyotech-Logo.png http://www.pharmajournalist.com/anixa-biosciences-and-ontochem-announce-collaboration-to-develop-novel-covid-19-therapeutics/ 2020-04-24T08:01:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Anixa_Logo.jpg http://www.pharmajournalist.com/mogrify-and-sangamo-announce-collaboration-and-exclusive-license-agreement-for-mogrifys-ipsc-and-esc-derived-regulatory-t-cells/ 2020-04-24T08:03:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Mogrify-Logo.png http://www.pharmajournalist.com/aptar-and-sonmol-partner-to-develop-digital-platform-for-respiratory-related-therapies/ 2020-04-24T08:05:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Aptar-Pharma-Logo.jpg http://www.pharmajournalist.com/targovax-and-valo-therapeutics-enter-collaboration-to-develop-ras-neoantigen-coating-of-oncos-viruses-using-pepticrad-technology/ 2020-04-24T08:07:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/targovax-logo.jpg http://www.pharmajournalist.com/prothera-biologics-and-takeda-to-develop-novel-plasma-derived-therapy-based-on-iaip/ 2020-04-24T08:09:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/catalent-biologics-completes-14-million-commercial-packaging-expansion-at-its-bloomington-indiana-facility/ 2020-04-24T08:14:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/askbio-acquires-brainvectis-to-expand-its-clinical-pipeline-for-neurodegenerative-diseases/ 2020-04-24T08:17:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/AskBio-Logo.jpe http://www.pharmajournalist.com/diamond-pharma-services-acquires-pharmacentral-to-strengthen-pharmacovigilance-division/ 2020-04-24T08:20:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Diamond-Pharma-Services.jpg http://www.pharmajournalist.com/registration-opens-for-smis-inaugural-aseptic-processing-conference/ 2020-04-27T08:32:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Aseptic-Processing-Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-interview-with-team-consulting-released-for-injectable-drug-delivery-2020/ 2020-04-27T10:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Injectable-Drug-Delivery_Pharma-Journalist.jpg http://www.pharmajournalist.com/top-level-industry-professionals-to-speak-at-pain-therapeutics-conference-in-2-weeks/ 2020-04-27T13:54:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics_Pharma-Journalist_Remote-Access.jpg http://www.pharmajournalist.com/workshop-overview-for-oligonucleotide-therapeutics-and-delivery-2020/ 2020-04-28T08:55:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide.jpg http://www.pharmajournalist.com/shionogi-accelerates-development-of-potential-covid-19-treatments-and-vaccine/ 2020-04-29T12:29:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/shionogi-logo.jpg http://www.pharmajournalist.com/cepi-announces-covid-19-vaccine-development-partnership-with-clover-biopharmaceuticals/ 2020-04-29T12:34:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CEPI-Logo.jpg http://www.pharmajournalist.com/santhera-and-cshl-to-investigate-lonodelestat-pol6014-in-covid-19-related-ards/ 2020-04-29T12:36:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Santhera-Pharma-Logo.jpg http://www.pharmajournalist.com/challenges-in-supply-and-partner-sourcing-for-stem-gene-clinical-trial-supply-a-virtual-experience/ 2020-04-29T16:01:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CTSWC-300X250-virtual.png http://www.pharmajournalist.com/gsk-gets-fda-approval-for-expanded-use-of-ovarian-cancer-drug-zejula/ 2020-05-01T08:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/atreca-beigene-and-igm-biosciences-agree-to-collaborate-on-novel-antibody-treatment-for-covid-19/ 2020-05-01T08:53:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/igm-biosciences.jpg http://www.pharmajournalist.com/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine/ 2020-05-01T08:55:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19/ 2020-05-01T08:57:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/uq-covid-19-vaccine-shown-to-induce-potent-protective-response-in-pre-clinical-trials/ 2020-05-01T09:02:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/team-member-pipetting-small.jpg https://pharmajournalist.com/wp-content/uploads/2020/05/team-member-pipetting-small.jpg http://www.pharmajournalist.com/pneumagen-ltd-announces-positive-anti-viral-activity-for-novel-glycan-approach-in-preventing-coronavirus-covid-19-infections/ 2020-05-01T09:07:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/kamada-and-kedrion-to-develop-immunoglobulin-product-for-covid-19/ 2020-05-01T09:10:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/kamada-pharmaceuticals.png http://www.pharmajournalist.com/scancell-to-initiate-development-of-novel-dna-vaccine-against-covid-19/ 2020-05-01T09:22:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/scancell-logo.jpg http://www.pharmajournalist.com/affinivax-announces-120-million-series-b-financing-to-advance-pipeline-of-novel-maps-vaccines-and-immunotherapies/ 2020-05-01T09:25:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Affinivax_Logo.png http://www.pharmajournalist.com/takeda-continues-divestiture-strategy-with-sale-of-select-otc-and-non-core-assets-in-europe-to-orifarm-for-up-to-approximately-670m-usd/ 2020-05-01T09:29:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/wuxi-biologics-and-aravive-form-strategic-collaboration/ 2020-05-01T09:32:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/trio-and-ajinomoto-enter-into-a-development-collaboration-for-a-novel-antibody-therapeutic/ 2020-05-01T09:55:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/catalent-signs-agreement-with-jj-to-be-u-s-manufacturing-partner-for-lead-covid-19-vaccine-candidate/ 2020-05-01T09:57:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/bioduro-neox-partner-to-create-next-generation-antibody-discovery-platform/ 2020-05-01T10:00:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/BioDuro.jpg http://www.pharmajournalist.com/q2earths-bioscience-subsidiary-qsam-therapeutics-signs-license-for-promising-drug-to-treat-bone-cancer/ 2020-05-01T10:03:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/q2earth-logo.jpg http://www.pharmajournalist.com/jcr-pharmaceuticals-announces-completion-of-acquisition-of-armagen-inc/ 2020-05-01T10:19:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/ArmaGen-Logo.jpg http://www.pharmajournalist.com/applied-biomath-llc-announces-collaboration-with-xilio-therapeutics/ 2020-05-01T10:20:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/applied-biomath-logo.png http://www.pharmajournalist.com/sutro-biopharma-announces-encouraging-interim-phase-1-clinical-data-for-stro-002-antibody-drug-conjugate-in-ovarian-cancer/ 2020-05-01T10:24:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/SUTRO-Biopharma-Logo.jpg http://www.pharmajournalist.com/fda-approves-additional-dosage-of-keytruda-across-all-adult-indications/ 2020-05-01T10:27:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/quotient-sciences-and-cytoagents-accelerate-potential-treatment-for-covid-19-cytokine-storm/ 2020-05-01T10:32:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Quotient-Sciences-Logo.jpg http://www.pharmajournalist.com/novartis-announces-plan-to-initiate-clinical-trial-of-canakinumab-for-patients-with-covid-19-pneumonia/ 2020-05-01T10:33:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/merck-and-isb-collaborate-to-define-molecular-mechanisms-of-sars-cov-2-infection-and-identify-potential-prognostic-biomarkers/ 2020-05-01T10:35:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/moderna-and-lonza-to-manufacture-mrna-1273-against-novel-coronavirus/ 2020-05-01T10:39:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/takeda-gets-fda-breakthrough-therapy-status-for-mobocertinib-to-treat-certain-type-of-lung-cancer/ 2020-05-01T10:41:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/notified-body-bsi-group-to-lead-a-workshop-during-the-pre-filled-syringes-san-francisco-conference/ 2020-05-04T11:01:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/fda-approves-new-treatment-for-a-type-of-heart-failure/ 2020-05-08T05:46:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/alexion-to-acquire-portola/ 2020-05-08T05:47:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/menarini-group-to-acquire-stemline-therapeutics-in-transaction-valued-at-up-to-677-million/ 2020-05-08T05:49:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Stemline-logo.png http://www.pharmajournalist.com/lilly-and-junshi-to-co-develop-antibody-therapies-for-the-prevention-and-treatment-of-covid-19/ 2020-05-08T05:51:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/vaxxel-acquires-transgenes-duckcelt-t17-cell-line-to-develop-industrial-scale-vaccines-against-respiratory-viruses/ 2020-05-08T05:54:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Transgene-Logo.png http://www.pharmajournalist.com/gilead-announces-approval-of-veklury-remdesivir-in-japan-for-patients-with-severe-covid-19/ 2020-05-08T05:56:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/pfizer-and-biontech-dose-first-participants-in-the-u-s-as-part-of-global-covid-19-mrna-vaccine-development-program/ 2020-05-08T05:59:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/inovio-expands-manufacturing-of-covid-19-dna-vaccine-ino-4800-with-new-funding-from-cepi/ 2020-05-08T06:01:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Inovio-pharma.jpg http://www.pharmajournalist.com/laurent-receives-health-canadas-approval-to-initiate-covid-19-clinical-trial/ 2020-05-08T06:03:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Laurent-Pharma-Logo.jpg http://www.pharmajournalist.com/bicycle-therapeutics-announces-first-patient-dosed-in-phase-i-dose-escalation-of-bt5528-in-combination-with-nivolumab/ 2020-05-08T06:08:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/lineage-cell-therapeutics-announces-early-exercise-of-option-with-cancer-research-uk-for-immuno-oncology-cell-therapy-program/ 2020-05-08T06:12:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Lineage_Logo.png http://www.pharmajournalist.com/acceleron-receives-priority-medicines-prime-designation-from-ema-for-sotatercept-in-pah/ 2020-05-08T06:16:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/logo-acceleron.png http://www.pharmajournalist.com/arcturus-therapeutics-and-catalent-announce-partnership-to-manufacture-mrna-based-covid-19-vaccine/ 2020-05-08T06:19:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Arcturus-Therapeutics.jpg http://www.pharmajournalist.com/novartis-receives-chmp-positive-opinion-for-enerzair-breezhaler-qvm149/ 2020-05-08T06:21:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/agc-biologics-partners-with-faron-pharmaceuticals-to-manufacture-cancer-treatment/ 2020-05-08T06:26:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/ptc-therapeutics-to-acquire-censa-pharmaceuticals/ 2020-05-08T06:28:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/PTC-Therapeutics.jpg http://www.pharmajournalist.com/zyus-collaborates-with-usasks-vido-intervac-to-develop-a-plant-based-vaccine-for-covid-19/ 2020-05-08T06:30:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/ZYUS_logo.jpg http://www.pharmajournalist.com/schreiner-medipharm-supplies-booklet-label-for-clinical-trial-at-sanofi/ 2020-05-08T06:35:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/SMP_Booklet-Label_Sanofi.jpg https://pharmajournalist.com/wp-content/uploads/2020/05/SMP_Booklet-Label_Sanofi.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-announces-sars-cov-2-globalaccess-sequencing-program/ 2020-05-08T06:36:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/enlivex-announces-initiation-of-phase-ii-trial-of-allocetra-in-covid-19-patients/ 2020-05-08T06:39:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/ENLIVEX-Logo.jpg http://www.pharmajournalist.com/cluepoints-covid-19-support-benefits-over-200-clinical-studies-directly-affected-by-the-pandemic/ 2020-05-08T07:04:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Clue-Points-Logo.png http://www.pharmajournalist.com/humanigen-first-patient-dosed-in-fda-approved-phase-iii-lenzilumab-study-for-covid-19/ 2020-05-08T07:06:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/recipharm-secures-supply-of-drug-substance-and-commences-manufacture-of-chloroquine-phosphate/ 2020-05-08T07:08:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/avrobio-and-magenta-therapeutics-announce-collaboration/ 2020-05-08T07:11:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/the-healthcare-industry-will-never-be-the-same-after-covid19/ 2020-05-11T13:31:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Baner-Digital-Helath-Online-Summit-300_250.png http://www.pharmajournalist.com/nagy-habib-professor-of-surgery-and-co-founder-of-mina-therapeutics-will-be-presenting-at-oligonucleotide-therapeutics-and-delivery-2020/ 2020-05-12T07:46:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide.jpg http://www.pharmajournalist.com/challenges-in-a-remote-workforce-outsourcing-in-clinical-trials-a-virtual-experience/ 2020-05-13T09:55:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/OCT-virtual-banner-300x250-1.png http://www.pharmajournalist.com/digital-agenda-revealed-innate-immune-stimulating-therapies/ 2020-05-14T08:08:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Pharma-Journalist-Banner-300x250px.png http://www.pharmajournalist.com/hit-the-jak-pot-in-global-race-to-treat-covid-19/ 2020-05-15T07:59:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Pharma-Journalist-300x250px-Banner.png http://www.pharmajournalist.com/new-date-announced-for-smis-pharmaceutical-microbiology-east-coast-conference/ 2020-05-15T08:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/P-316-300-x-250-Pharma-Microbiology-EC-2020.jpg http://www.pharmajournalist.com/cytoagents-receives-nih-funding-to-accelerate-treatment-for-cytokine-storm/ 2020-05-15T09:53:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/CytoAgents-Logo.jpg http://www.pharmajournalist.com/boehringer-acquires-northern-biologics-preclinical-cancer-antibody-pipeline/ 2020-05-15T09:57:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/boehringer-ingelheim-collaborates-with-cdr-life/ 2020-05-15T09:59:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/sarclisa-isatuximab-phase-3-ikema-trial-meets-primary-endpoint-early-in-patients-with-relapsed-multiple-myeloma/ 2020-05-15T10:02:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/moderna-receives-fda-fast-track-designation-for-mrna-vaccine-mrna-1273-against-novel-coronavirus/ 2020-05-15T10:13:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/acer-therapeutics-to-develop-emetine-as-potential-covid-19-treatment-in-collaboration-with-ncats/ 2020-05-15T10:15:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/dyno-therapeutics-emerges-from-stealth-to-transform-gene-therapy-using-artificial-intelligence/ 2020-05-15T10:19:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/DYNO-Therapeutics-Logo.jpg http://www.pharmajournalist.com/enhertu-granted-breakthrough-therapy-designation-in-the-us-for-her2-positive-metastatic-gastric-cancer/ 2020-05-15T10:35:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/sorrento-and-mount-sinai-to-jointly-develop-covi-shield-antibody-therapy-targeting-sars-cov-2-infection-covid-19/ 2020-05-15T10:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/neuraptive-therapeutics-announces-fda-has-granted-fast-track-designation-to-ntx-001-clinical-development-program-for-treatment-of-patients-with-peripheral-nerve-injuries/ 2020-05-15T10:41:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Neuraptive-Therapeutics-Logo.jpg http://www.pharmajournalist.com/takeda-china-announces-adcetris-brentuximab-vedotin-is-approved-for-the-treatment-of-adult-patients-with-cd30-positive-lymphomas/ 2020-05-15T10:44:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/cipla-enters-into-a-licensing-agreement-with-gilead-to-expand-access-to-covid-19-treatment/ 2020-05-15T10:45:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cipla-Logo.png http://www.pharmajournalist.com/catalent-signs-development-agreement-with-ennaid-therapeutics-on-its-covid-19-lead-program/ 2020-05-15T10:47:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/seattle-genetics-gets-approval-of-tukysa-in-switzerland-for-metastatic-her2-positive-breast-cancer/ 2020-05-15T10:52:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Seattle-Childrens.jpg http://www.pharmajournalist.com/ocular-therapeutix-announces-first-patient-dosed-in-phase-1-clinical-trial-of-otx-csi-for-the-treatment-of-dry-eye-disease/ 2020-05-15T10:55:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Ocular-Therapeutix-Logo.png http://www.pharmajournalist.com/crispr-and-vertex-announce-fda-rmat-designation-granted-to-ctx001-to-treat-severe-hemoglobinopathies/ 2020-05-15T10:58:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/glenmark-initiates-phase-3-clinical-trials-on-antiviral-favipiravir-for-covid-19-patients-in-india/ 2020-05-15T11:01:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/fda-authorizes-first-antigen-test-to-help-in-the-rapid-detection-of-the-virus-that-causes-covid-19-in-patients/ 2020-05-15T11:03:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/themis-collaborates-with-abl-europe-to-manufacture-its-sars-cov-2-vaccine-candidate-in-france/ 2020-05-15T11:04:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/bellerophon-therapeutics-announces-fda-clears-initiation-of-phase-3-study-for-inopulse-inhaled-nitric-oxide-therapy-to-treat-covid-19/ 2020-05-15T11:06:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Bellerophon-Logo.jpg http://www.pharmajournalist.com/legend-biotech-and-noile-immune-biotech-announce-collaborative-research-and-licensing-agreement/ 2020-05-15T11:09:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Legend-Biotech-Logo.jpg http://www.pharmajournalist.com/skyhawk-therapeutics-announces-expansion-of-its-collaboration-agreement-with-merck/ 2020-05-15T11:12:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/skyhawk_therapeutics_logo.png http://www.pharmajournalist.com/recursion-enters-into-global-licensing-agreement-with-takeda-to-develop-tak-733-in-hereditary-cancer-syndrome/ 2020-05-15T11:17:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Recursion-Logo.jpg http://www.pharmajournalist.com/colorcon-launches-soteriarx-on-dose-authentication-technology-platform/ 2020-05-15T11:23:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/SoteriaRxTM.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/05/SoteriaRxTM.jpg http://www.pharmajournalist.com/biomed-x-institute-launches-rapid-antiviral-response-platform-to-prevent-future-pandemics/ 2020-05-15T11:25:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/evonik-commissions-advanced-biomaterials-production-facility-for-pharmaceutical-and-medical-applications-in-birmingham-alabama/ 2020-05-15T11:27:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Evonik.jpg http://www.pharmajournalist.com/registration-is-now-open-for-the-2nd-annual-wearable-injectors-and-connected-devices-conference-2020/ 2020-05-19T09:48:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/300x250.jpg http://www.pharmajournalist.com/jace-blackburn-smart-device-engineer-genentech-will-be-presenting-at-the-inaugural-pre-filled-syringes-san-francisco/ 2020-05-19T09:55:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/digital-health-online-summit/ 2020-05-19T10:52:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/DHOS-Banner-2.png http://www.pharmajournalist.com/registration-is-open-for-smis-2nd-annual-next-generation-pharmaceutical-cleanroom/ 2020-05-20T09:47:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/P-330-Cleanroom-Technology-2020-300x250-banner.jpg http://www.pharmajournalist.com/astrazeneca-advances-response-to-global-covid-19-challenge-as-it-receives-first-commitments-for-oxfords-potential-new-vaccine/ 2020-05-22T09:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/inovios-covid-19-dna-vaccine-ino-4800-demonstrates-robust-neutralizing-antibody-and-t-cell-immune-responses-in-preclinical-models/ 2020-05-22T09:38:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Inovio-Logo.png http://www.pharmajournalist.com/vividion-therapeutics-announces-drug-discovery-collaboration-with-roche-focused-on-novel-e3-ligases/ 2020-05-22T09:41:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/phlow-corporation-awarded-354-million-contract-to-manufacture-essential-medicines-in-shortage/ 2020-05-22T09:43:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/avexis-receives-ec-approval-and-activates-day-one-access-program-for-zolgensma/ 2020-05-22T09:46:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/cipla-receives-final-approval-for-generic-version-of-migranal/ 2020-05-22T09:48:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Cipla-Logo.png http://www.pharmajournalist.com/astrazeneca-gets-breakthrough-status-for-enhertu-to-treat-nsclc/ 2020-05-22T09:50:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/kleo-pharmaceuticals-and-celularity-enter-into-research-collaboration/ 2020-05-22T09:54:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Kleo-Pharma-Logo.png http://www.pharmajournalist.com/innovent-biologics-and-md-anderson-announce-a-strategic-collaboration-to-develop-anti-pd-1-therapy-tyvyt-sintilimab-injection-in-rare-cancers/ 2020-05-22T09:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/innovent-biologics-logo.png http://www.pharmajournalist.com/pharmajet-and-abnova-partner-to-develop-and-deliver-covid-19-mrna-vaccine-using-needle-free-injection-technology/ 2020-05-22T09:57:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/pharmajet-needle-free-injection.jpg http://www.pharmajournalist.com/amplyx-pharmaceuticals-advances-development-of-novel-antifungal-fosmanogepix/ 2020-05-22T10:06:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/amplyx-logo.jpg http://www.pharmajournalist.com/kindred-biosciences-announces-covid-19-vaccine-manufacturing-agreement-with-vaxart/ 2020-05-22T10:08:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Kindred-Bio-Logo.png http://www.pharmajournalist.com/gsk-partners-with-samsung-biologics-to-secure-additional-manufacturing-capacity-for-innovative-biopharmaceutical-portfolio/ 2020-05-22T10:09:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/sunovion-gets-fda-nod-for-kynmobi-to-treat-parkinsons-disease-off-episodes/ 2020-05-22T10:12:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sunovion-logo.jpg http://www.pharmajournalist.com/gilead-and-galapagos-announce-positive-topline-results-of-phase-2b-3-trial-of-filgotinib-in-moderately-to-severely-active-ulcerative-colitis/ 2020-05-22T10:16:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/fda-approves-octapharma-usa-investigational-new-drug-application-for-severe-covid-19-patients/ 2020-05-22T10:17:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lynparza-approved-in-the-us-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-05-22T10:18:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/rallybio-raises-145m-in-series-b-round-for-developing-rare-disease-drug-candidates/ 2020-05-22T10:39:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Rallybio-Logo.jpg http://www.pharmajournalist.com/tolero-pharma-submits-investigational-new-drug-application-for-experimental-pkm2-activator-tp-1454/ 2020-05-22T10:41:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/moderna-announces-positive-interim-phase-1-data-for-its-mrna-vaccine-mrna-1273-against-novel-coronavirus/ 2020-05-22T10:43:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/fda-grants-full-approval-of-deciphera-pharmaceuticals-qinlock-ripretinib-for-the-treatment-of-fourth-line-gastrointestinal-stromal-tumor/ 2020-05-22T10:46:03+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/deciphera-logo.png http://www.pharmajournalist.com/catalent-announces-acquisition-of-japanese-facility-to-provide-local-and-global-clinical-supply-solutions/ 2020-05-22T10:48:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/janssen-announces-phase-1-results-for-amivantamab-in-advanced-nsclc-harbouring-exon-20-insertion-mutations/ 2020-05-22T11:06:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/gilead-and-arcus-biosciences-partner-to-develop-cancer-drugs/ 2020-05-29T08:24:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/abcellera-closes-105-million-series-b-financing-to-further-advance-world-leading-antibody-drug-discovery-platform/ 2020-05-29T08:29:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/iavi-and-merck-collaborate-to-develop-vaccine-against-sars-cov-2/ 2020-05-29T08:32:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-approves-dupixent-dupilumab-for-children-aged-6-to-11-years-with-moderate-to-severe-atopic-dermatitis/ 2020-05-29T08:36:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/fda-approves-takedas-alunbrig-for-rare-and-serious-form-of-lung-cancer/ 2020-05-29T08:41:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/tavotek-announces-a-research-agreement-with-genmab-for-the-development-of-bispecific-antibodies/ 2020-05-29T08:44:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/TAVOTEK-Logo.jpg http://www.pharmajournalist.com/oncodesign-and-hitgen-announce-a-strategic-partnership-in-idds/ 2020-05-29T08:46:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Oncodesign.jpg http://www.pharmajournalist.com/archerdx-announces-strategic-collaboration-with-astrazeneca/ 2020-05-29T08:49:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/ARCHER-Logo.jpg http://www.pharmajournalist.com/repare-therapeutics-announces-multi-target-discovery-collaboration-with-bristol-myers-squibb/ 2020-05-29T08:52:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Repare-Therapeutics-Logo.jpg http://www.pharmajournalist.com/edigene-and-immunochina-announce-rd-collaboration-to-develop-allogeneic-car-t-therapy-for-cancer/ 2020-05-29T08:55:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Edigene_Logo.jpg http://www.pharmajournalist.com/avexis-receives-positive-chmp-opinion-for-zolgensma/ 2020-05-29T09:15:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/irbms-advent-announces-manufacture-of-13000-doses-of-covid-19-vaccine-for-use-in-phase-2-3-clinical-trials-by-the-university-of-oxford/ 2020-05-29T09:25:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/irbm-advent-doses-covid19-vaccine.jpg http://www.pharmajournalist.com/roche-initiates-phase-iii-clinical-trial-of-actemra-roactemra-plus-remdesivir-in-hospitalised-patients-with-severe-covid-19-pneumonia/ 2020-05-29T09:28:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/almac-group-supports-two-covid-19-clinical-studies-in-sub-saharan-africa/ 2020-05-29T09:30:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/HSA-Inspection_Almac-Group.jpg http://www.pharmajournalist.com/lonza-and-sanquin-partner-for-commercialization-of-specialized-mat-reagents-for-accurate-and-reliable-in-vitro-pyrogen-testing/ 2020-05-29T09:32:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/merck-and-ridgeback-bio-collaborate-to-advance-development-of-novel-antiviral-candidate-eidd-2801/ 2020-05-29T09:34:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/ajinomoto-bio-pharma-services-signs-manufacturing-agreement-with-humanigen/ 2020-05-29T09:39:01+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Ajinomoto-Bio-Pharma.jpg http://www.pharmajournalist.com/novasep-and-lysogene-announce-their-new-collaboration-for-development-and-production-of-gm1-gangliosidosis-gene-therapy-product/ 2020-05-29T09:41:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/rentschler-biopharma-extends-collaboration-with-genmab-to-u-s-facility/ 2020-05-29T09:44:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Rentschler-.jpg http://www.pharmajournalist.com/novavax-expands-large-scale-global-manufacturing-capacity/ 2020-05-29T09:47:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/montefiore-and-einstein-test-a-new-drug-combination-to-conquer-covid-19/ 2020-05-29T10:23:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Montefiore-Logo.jpg http://www.pharmajournalist.com/merck-to-acquire-themis/ 2020-05-29T10:26:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/chi-med-and-beigene-enter-into-clinical-collaboration-to-evaluate-combinations-of-surufatinib-and-fruquintinib-with-tislelizumab/ 2020-05-29T10:30:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-extends-collaboration-with-biognosys-to-enhance-protein-quantitation-mass-spectrometry-workflows/ 2020-05-29T10:31:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/bristol-myers-squibb-receives-european-commission-approval-for-zeposia-ozanimod/ 2020-05-29T10:36:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fda-grants-priority-review-of-nucala-for-patients-with-hypereosinophilic-syndrome-hes/ 2020-05-29T10:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/phasebio-launches-clinical-trial-to-evaluate-pb1046-as-a-treatment-for-hospitalized-covid-19-patients/ 2020-05-29T10:41:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/PhaseBio-Logo.jpg http://www.pharmajournalist.com/updates-from-dermavant-eli-lilly-celon-pharma-more-jak-inhibitors/ 2020-06-03T08:57:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Pharma-Journalist-300x250px-Banner.png http://www.pharmajournalist.com/join-the-leaders-in-sting-tlr-therapies/ 2020-06-03T08:59:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/Pharma-Journalist-Banner-300x250px.png http://www.pharmajournalist.com/memo-therapeutics-ag-identifies-potent-sars-cov-2-neutralizing-antibodies-from-the-blood-of-recovered-covid-19-patients/ 2020-06-05T08:29:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Memo-Therapeutics-Logo.jpg http://www.pharmajournalist.com/astrazeneca-teams-up-with-accent-therapeutics-for-cancer-therapies/ 2020-06-05T08:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novavax-selects-agc-biologics-to-manufacture-matrix-m-adjuvant-for-novel-covid-19-vaccine/ 2020-06-05T08:34:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/agc-biologics-acquires-commercial-facility-expanding-global-service-offerings/ 2020-06-05T08:36:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Boulder-CO-Facility-1.jpg https://pharmajournalist.com/wp-content/uploads/2020/06/Boulder-CO-Facility-1.jpg http://www.pharmajournalist.com/european-commission-approves-sarclisa-for-adults-with-relapsed-and-refractory-multiple-myeloma/ 2020-06-05T08:38:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/baylor-texas-childrens-to-accelerate-covid-19-vaccine-testing/ 2020-06-05T08:40:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/tubes.jpg http://www.pharmajournalist.com/intravacc-and-epivax-team-up-in-development-of-covid-19-emerging-vaccine/ 2020-06-05T08:42:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/abbvie-and-jacobio-announce-strategic-collaboration-to-advance-shp2-inhibitors/ 2020-06-05T08:44:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/regeneron-and-intellia-therapeutics-expand-collaboration-to-develop-crispr-cas9-based-treatments/ 2020-06-05T08:46:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/lynparza-recommended-for-approval-in-eu-by-chmp-for-brca-mutated-metastatic-pancreatic-cancer/ 2020-06-05T08:48:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/astrazenecas-heart-disease-drug-brilinta-gets-fda-approval/ 2020-06-05T08:50:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/celltrion-announces-positive-pre-clinical-results-for-covid-19-antiviral-antibody-treatment/ 2020-06-05T08:51:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/melinta-therapeutics-to-acquire-tetraphase-pharmaceuticals/ 2020-06-05T08:55:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/melinta-logo.png http://www.pharmajournalist.com/innovent-biologics-and-lilly-jointly-announced-the-long-term-follow-up-results-of-tyvyt/ 2020-06-05T08:57:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/predictive-oncology-completes-acquisition-of-soluble-therapeutics-and-biodtech/ 2020-06-05T09:00:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Predictive-Oncology-Logo.png http://www.pharmajournalist.com/pharmabcine-signs-a-license-agreement-with-wincal-biopharm-to-expand-indications-of-pharmabcines-existing-assets-to-non-oncology-areas/ 2020-06-05T09:04:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/janssens-tremfya-delivers-improvement-in-psoriatic-arthritis-joint-and-skin-symptoms-at-week-52-in-phase-3-trials/ 2020-06-05T11:40:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/octapharma-usa-extends-funding-for-covid-19-study-following-positive-preliminary-research-data/ 2020-06-05T11:44:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Octapharma-Logo.png http://www.pharmajournalist.com/pierre-fabre-gets-ec-nod-for-braftovi-plus-cetuximab-to-treat-brafv600e-mutant-mcrc/ 2020-06-05T11:50:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Pierre-Fabre-logo.png http://www.pharmajournalist.com/bristol-myers-squibb-announces-positive-topline-results-from-true-north-trial-evaluating-zeposia-in-ulcerative-colitis/ 2020-06-05T11:53:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fsd-pharma-receives-fda-approval-to-design-a-phase-2a-clinical-trial-to-treat-patients-with-suspected-or-confirmed-covid-19-diagnosis/ 2020-06-05T12:03:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/aveo-oncology-announces-fda-acceptance-for-filing-of-an-nda-for-tivozanib-as-treatment-of-relapsed-or-refractory-renal-cell-carcinoma/ 2020-06-05T12:05:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/aveo-oncology1.jpg http://www.pharmajournalist.com/codiak-biosciences-collaborates-with-ragon-institute-to-evaluate-the-exovacc-vaccine-platform-in-sars-cov-2-and-hiv/ 2020-06-05T12:08:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Codiak_Logo.jpg http://www.pharmajournalist.com/agex-therapeutics-and-imstem-biotechnology-sign-non-binding-letter-of-intent/ 2020-06-05T12:10:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/AGEX_Logo.jpg http://www.pharmajournalist.com/human-factors-and-risk-management-leading-post-conference-workshop-at-pre-filled-syringes-san-francisco/ 2020-06-08T09:46:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/astrazeneca-to-lead-workshop-at-wearable-injectors-and-connected-devices-conference-2020/ 2020-06-10T12:49:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/300x250.jpg http://www.pharmajournalist.com/takeda-to-divest-otc-and-select-non-core-assets-in-asia-pacific-to-celltrion-for-up-to-278-million-usd/ 2020-06-12T12:33:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sofinnova-partners-announces-sale-of-corvidia-therapeutics-to-novo-nordisk/ 2020-06-12T12:35:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/abbvie-and-genmab-announce-broad-oncology-collaboration/ 2020-06-12T12:38:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/eib-to-provide-biontech-with-up-to-e100-million-in-debt-financing-for-covid-19-vaccine-development/ 2020-06-12T12:42:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/fujifilm-to-invest-928-million-usd-to-expand-its-large-scale-biologics-production-facility-in-denmark/ 2020-06-12T12:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/innovent-and-roche-enter-into-a-strategic-collaboration/ 2020-06-12T12:52:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/ucb-acquires-engage-therapeutics/ 2020-06-12T13:07:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/oxford-biomedica-signs-five-year-collaboration-agreement-with-the-vaccines-manufacturing-and-innovation-centre/ 2020-06-12T13:10:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg http://www.pharmajournalist.com/abbvie-and-partners-to-develop-monoclonal-antibody-against-covid-19/ 2020-06-12T13:12:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/hitgen-and-evotec-se-enter-into-drug-discovery-research-collaboration/ 2020-06-12T13:16:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/alphamab-oncology-and-sanofi-enter-collaboration-on-kn026-in-her2-breast-cancer/ 2020-06-12T13:19:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/evox-therapeutics-announces-a-multi-target-rnai-and-antisense-research-collaboration-and-license-agreement-with-lilly/ 2020-06-12T13:24:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Evox-Therapeutics-Logo.gif http://www.pharmajournalist.com/lyvgen-announces-clinical-trial-collaboration-with-msd/ 2020-06-12T13:28:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/delmar-to-acquire-adgero-biopharmaceuticals-expands-late-stage-oncology-pipeline/ 2020-06-12T13:31:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/DelMar-Pharma-Logo.jpg http://www.pharmajournalist.com/bryologyx-announces-agreements-with-neurotrope-to-acquire-bryostatin-1-immuno-oncology-data-package-supply-synthetic-bryostatin-1/ 2020-06-12T13:34:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Bryologyx-Logo.jpg http://www.pharmajournalist.com/sobi-and-selecta-announce-strategic-licensing-agreement-for-sel-212/ 2020-06-12T13:35:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/leap-therapeutics-announces-oprhan-drug-designation-of-dkn-01-for-the-treatment-of-gastric-and-gastroesophageal-junction-cancer/ 2020-06-12T13:38:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Leap-Therapeutics-Logo.jpg http://www.pharmajournalist.com/clovis-oncology-completes-target-enrollment-in-athena-trial-in-advanced-ovarian-cancer/ 2020-06-12T13:40:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Clovis-Oncology-Logo.png http://www.pharmajournalist.com/pfizer-announces-positive-top-line-results-from-jade-teen-trial-of-abrocitinib-in-adolescents-with-moderate-to-severe-atopic-dermatitis/ 2020-06-12T13:41:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/vertex-gets-ec-nod-for-kalydeco-to-treat-children-and-adolescents-with-cystic-fibrosis/ 2020-06-12T13:42:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/ubivac-announces-clinical-trial-collaboration-with-bristol-myers-squibb/ 2020-06-12T13:44:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/relief-therapeutics-and-neurorx-expand-clinical-trial-of-rlf-100-to-all-patients-with-critical-covid-19-and-respiratory-failure/ 2020-06-12T13:47:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Relief-Therapeutics-Logo.png http://www.pharmajournalist.com/lilly-announces-start-of-a-phase-1-study-for-its-second-potential-covid-19-antibody-treatment/ 2020-06-12T13:48:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/illumina-receives-first-fda-emergency-use-authorization-for-a-sequencing-based-covid-19-diagnostic-test/ 2020-06-12T13:52:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/grifols-starts-production-of-its-hyperimmune-immunoglobulin-as-a-potential-passive-immune-therapy-against-covid-19/ 2020-06-12T13:53:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Grifols.jpg http://www.pharmajournalist.com/arena-international-announces-the-brand-new-direct-to-patient-and-virtual-clinical-trials-digital-experience/ 2020-06-17T10:24:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Arena-International.jpg http://www.pharmajournalist.com/tonix-pharmaceuticals-and-southern-research-announce-expansion-of-covid-19-vaccine-collaboration/ 2020-06-19T10:29:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/orca-bio-emerges-with-nearly-300-million-to-transform-allogeneic-cell-therapy/ 2020-06-19T10:34:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/orca-bio-logo.png http://www.pharmajournalist.com/pds-biotechnology-and-farmacore-biotechnology-announce-co-development-of-pds0204-covid-19-vaccine/ 2020-06-19T10:37:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/PDS-Biotechnology-Logo.png http://www.pharmajournalist.com/neurocrine-and-takeda-announce-collaboration-to-develop-and-commercialize-potential-therapies-for-psychiatric-disorders/ 2020-06-19T10:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sanofi-invests-to-make-france-its-world-class-center-of-excellence-in-vaccine-research-and-production/ 2020-06-19T10:41:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/german-federal-government-invests-300-million-euros-in-curevac/ 2020-06-19T10:46:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Curevac-logo.png http://www.pharmajournalist.com/daiichi-sankyo-announces-decision-to-develop-vaccine-in-japan-for-novel-corona-virus-infection-covid-19/ 2020-06-19T10:48:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/fda-approves-drug-to-treat-infants-and-children-with-hiv/ 2020-06-19T10:50:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astrazeneca-to-supply-europe-with-up-to-400-million-doses-of-oxford-universitys-vaccine-at-no-profit/ 2020-06-19T10:52:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/magenta-therapeutics-and-beam-therapeutics-announce-collaboration/ 2020-06-19T10:56:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Magenta-Therapeutics-Logo.jpg http://www.pharmajournalist.com/medrhythms-receives-fda-breakthrough-device-designation-for-chronic-stroke-digital-therapeutic/ 2020-06-19T11:00:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/MEDRhythms-Logo.jpg http://www.pharmajournalist.com/atum-and-phylex-biosciences-collaborate-to-accelerate-the-development-of-a-universal-sars-coronavirus-vaccine/ 2020-06-19T11:02:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/monopar-and-northstar-join-forces-to-develop-radio-immuno-therapeutics-rits-targeting-severe-covid-19/ 2020-06-19T11:05:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Monopar-Therapeutics-Logo.jpg http://www.pharmajournalist.com/isa-pharmaceuticals-strengthens-strategic-immuno-oncology-collaboration-with-regeneron/ 2020-06-19T11:09:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/ISA-Pharma-Logo.png http://www.pharmajournalist.com/lassen-therapeutics-launches-to-discover-and-develop-novel-antibody-therapeutics-including-lead-program-targeting-il-11-to-treat-fibrosis-and-oncology/ 2020-06-19T11:16:42+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Lassen_logo.jpg http://www.pharmajournalist.com/alpine-immune-sciences-and-abbvie-announce-option-and-license-agreement-for-the-development-and-commercialization-of-alpn-101/ 2020-06-19T11:19:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/sarepta-therapeutics-and-selecta-biosciences-enter-into-research-license-and-option-agreement/ 2020-06-19T11:21:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/roches-tecentriq-plus-chemotherapy-meets-goal-in-triple-negative-breast-cancer-trial/ 2020-06-19T11:26:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/interdisciplinary-consortium-receives-grant-to-develop-next-generation-cell-based-cancer-vaccines/ 2020-06-19T11:29:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Saint-Gobain_-_Kanyr.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/06/Saint-Gobain_-_Kanyr.jpg http://www.pharmajournalist.com/novartis-cosentyx-receives-fda-approval-for-new-indication-to-treat-active-non-radiographic-axial-spondyloarthritis/ 2020-06-19T11:31:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/ideaya-and-gsk-announce-a-broad-partnership-in-synthetic-lethality/ 2020-06-19T11:34:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/west-pharmaceutical-services-to-host-a-free-exclusive-webinar-on-prefilled-syringe-elastomer-components/ 2020-06-19T14:24:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/300x250-1.jpg https://pharmajournalist.com/wp-content/uploads/2020/06/1200x627-Both-Speakers-1.gif http://www.pharmajournalist.com/merck-completes-acquisition-of-themis/ 2020-06-19T14:30:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/merck-and-pfizers-sglt2-inhibitor-steglatro-meets-primary-endpoint-in-vertis-cv-trial/ 2020-06-19T14:32:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/jazz-pharmamar-get-fda-accelerated-approval-for-zepzelca-in-metastatic-sclc/ 2020-06-19T14:36:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Zepzelca.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/06/Zepzelca.jpg http://www.pharmajournalist.com/lilly-begins-a-phase-3-clinical-trial-with-baricitinib-for-hospitalized-covid-19-patients/ 2020-06-19T14:38:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/conference-chair-invitation-letter-for-smis-pharmaceutical-microbiology-east-coast-conference/ 2020-06-23T10:26:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/P-316-300-x-250-Pharma-Microbiology-EC-2020.jpg http://www.pharmajournalist.com/registration-opens-for-smis-4th-annual-ophthalmic-drugs-conference/ 2020-06-25T15:52:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/650x650.jpg https://pharmajournalist.com/wp-content/uploads/2020/06/650x650.jpg http://www.pharmajournalist.com/avalon-globocare-achieves-milestones-in-advancing-novel-intranasal-and-oral-covid-19-vaccine-candidate/ 2020-06-26T08:53:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/avalon-globocare.jpg http://www.pharmajournalist.com/moderna-and-catalent-announce-collaboration-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine-candidate/ 2020-06-26T08:56:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/allergan-and-molecular-partners-receive-complete-response-letter-from-fda-on-bla-for-abicipar-pegol/ 2020-06-26T08:58:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/yumanity-therapeutics-announces-strategic-research-collaboration-and-license-agreement-with-merck/ 2020-06-26T09:00:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-approves-fintepla-fenfluramine-for-the-treatment-of-seizures-associated-with-dravet-syndrome/ 2020-06-26T09:03:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/gilead-sciences-secures-exclusive-option-to-acquire-pionyr-immunotherapeutics/ 2020-06-26T09:05:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/sarepta-and-codiak-collaborate-to-research-and-develop-exosome-based-therapeutics-for-rare-diseases/ 2020-06-26T09:07:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/sanofi-and-translate-bio-expand-collaboration-to-develop-mrna-vaccines-across-all-infectious-disease-areas/ 2020-06-26T09:09:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/ascentage-pharma-enters-clinical-collaboration-to-evaluate-the-combination-of-bcl-2-and-btk-inhibitors/ 2020-06-26T09:15:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/agenus-and-betta-pharmaceuticals-enter-into-a-license-agreement-for-balstilimab-and-zalifrelimab-in-greater-china/ 2020-06-26T09:16:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agenus.jpg http://www.pharmajournalist.com/linnaeus-therapeutics-announces-clinical-trial-collaboration-agreement-with-merck/ 2020-06-26T09:18:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/century-therapeutics-announces-acquisition-of-empirica-therapeutics/ 2020-06-26T09:20:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Century-Therapeutics-Logo.jpg http://www.pharmajournalist.com/csl-behring-agrees-to-acquire-novel-late-stage-gene-therapy-candidate-for-hemophilia-b-patients-from-uniqure/ 2020-06-26T09:22:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/CSL-Behring.png http://www.pharmajournalist.com/replicate-bioscience-and-immunomic-therapeutics-form-collaboration-to-combat-infectious-diseases-and-cancers/ 2020-06-26T09:25:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Immunomic-Therapeutics-Logo.jpg http://www.pharmajournalist.com/aldevron-announces-agreement-with-ziopharm-oncology/ 2020-06-26T09:26:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/manufacturing-facility-aldevron.jpg http://www.pharmajournalist.com/theravance-biopharma-doses-first-patient-in-phase-2-covid-19-trial-with-jaki-inhibitor-td-0903/ 2020-06-26T09:30:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Theravance-Biopharma.jpg http://www.pharmajournalist.com/symbiosis-and-astrazeneca-sign-supply-agreement-for-sterile-manufacture-of-covid-19-vaccine-for-clinical-trials/ 2020-06-26T09:33:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Symbiosis-Facility-in-Stirling.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/06/Symbiosis-Facility-in-Stirling.jpg http://www.pharmajournalist.com/noxopharm-reports-covid-19-trial-program-to-commence-in-europe/ 2020-06-26T09:35:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/neurorx-relief-therapeutics-secure-fda-fast-track-status-for-covid-19-drug-candidate/ 2020-06-26T09:37:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/08/Relief-Therapeutics-Logo.png http://www.pharmajournalist.com/novaremed-announces-fda-approval-for-phase-2-clinical-study-of-nrd135s-e1-for-pdpn/ 2020-06-26T09:40:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Novaremed-Logo.jpg http://www.pharmajournalist.com/piramal-pharma-solutions-announces-acquisition-of-solid-oral-dosage-drug-product-facility-in-sellersville-pennsylvania-from-gw-laboratories/ 2020-06-26T09:43:37+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/Facility-in-Sellersville.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/06/Facility-in-Sellersville.jpg http://www.pharmajournalist.com/emd-serono-initiates-first-clinical-trial-of-tlr7-and-8-inhibitor-as-a-potential-treatment-for-severe-symptoms-of-covid-19-infection/ 2020-06-26T11:23:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/EMD-Serono.jpg http://www.pharmajournalist.com/ppd-expands-laboratory-test-portfolio-for-covid-19-therapy-and-vaccine-development-programs/ 2020-06-26T11:28:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/evotec-samsara-biocapital-and-kck-launch-autobahn-labs/ 2020-06-26T11:32:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/evotec.jpg http://www.pharmajournalist.com/labcorp-launches-new-neutralizing-antibody-test/ 2020-06-26T11:32:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/LabCorp.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-and-daiichi-sankyo-to-co-develop-global-companion-diagnostic-for-patients-with-non-small-cell-lung-cancer/ 2020-06-26T11:34:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/developing-custom-syringes-for-highly-viscous-formulations-to-be-discussed-at-the-pre-filled-syringes-san-francisco-conference/ 2020-06-30T08:12:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/PFS-San-Francisco.jpg http://www.pharmajournalist.com/rdif-and-chemrar-announce-increased-production-of-avifavir-for-treatment-of-coronavirus-and-begin-export-deliveries/ 2020-07-03T10:47:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/RDIF.jpg http://www.pharmajournalist.com/viiv-healthcare-announces-fda-approval-for-rukobia/ 2020-07-03T10:49:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/ViiV-Healthcare.png http://www.pharmajournalist.com/intravacc-to-in-license-cimcures-iboost-technology-expanding-its-vaccine-platform-portfolio/ 2020-07-03T10:52:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/novartis-announces-met-inhibitor-tabrecta-approved-in-japan-for-advanced-non-small-cell-lung-cancer-with-metex14/ 2020-07-03T10:54:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/jj-announces-european-commission-approval-for-janssens-preventive-ebola-vaccine/ 2020-07-03T10:57:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/meissa-vaccines-provides-a-pipeline-update-on-vaccine-candidates-for-covid-19-and-rsv/ 2020-07-03T11:00:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/tiziana-life-sciences-announces-agreement-with-stc-biologics-for-gmp-manufacturing/ 2020-07-03T11:05:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Tiziana-Life-Sciences.jpg http://www.pharmajournalist.com/fda-approves-roches-phesgo-for-her2-positive-breast-cancer/ 2020-07-03T11:07:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/gsk-receives-first-regulatory-approval-for-duvroq-daprodustat-in-japan-for-patients-with-anaemia-due-to-chronic-kidney-disease/ 2020-07-03T11:11:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/nordic-nanovectors-betalutin-receives-fast-track-designation-from-us-fda-for-marginal-zone-lymphoma/ 2020-07-03T11:17:21+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/nordic-nanovector-logo.jpg http://www.pharmajournalist.com/sfa-therapeutics-announces-fda-approval-to-begin-ind-trial/ 2020-07-03T11:19:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/biocare-medical-and-bethyl-laboratories-announce-strategic-partnership-for-antibody-development/ 2020-07-03T11:21:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/BIOCARE-Medical-Logo.png http://www.pharmajournalist.com/vitrac-therapeutics-initiated-global-clinical-development-of-vic-1911-licensed-from-taiho-pharmaceutical/ 2020-07-03T11:23:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/VITRIC_LOGO.jpg http://www.pharmajournalist.com/sinclair-research-announces-successful-validation-of-glp-ototoxicity-testing-services/ 2020-07-03T11:26:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/sinclair-research-logo.jpg http://www.pharmajournalist.com/carmine-therapeutics-and-takeda-collaborate-to-discover-and-develop-rare-disease-gene-therapies/ 2020-07-03T11:30:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Carmine-Therapeutics-Logo.jpg http://www.pharmajournalist.com/bioinvent-extends-research-collaboration-and-license-agreement-with-pfizer/ 2020-07-03T11:33:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/BioInvent-Logo.png http://www.pharmajournalist.com/aligos-therapeutics-and-ku-leuven-announce-collaboration-for-the-development-of-a-therapeutic-candidate-targeting-coronavirus/ 2020-07-03T11:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Aligos-Therapeutics-Logo.jpg http://www.pharmajournalist.com/sarepta-therapeutics-signs-agreement-with-hansa-biopharma-for-imlifidase/ 2020-07-03T11:37:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/kkr-to-acquire-a-controlling-stake-in-j-b-chemicals-pharmaceuticals/ 2020-07-03T11:42:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/KKR-logo.jpg http://www.pharmajournalist.com/daiichi-sankyo-expands-ds-1062-study-to-include-patients-with-triple-negative-breast-cancer/ 2020-07-03T11:44:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/pfizer-biontech-announce-early-positive-data-from-sars-cov-2-trial/ 2020-07-03T11:48:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/exelixis-initiates-phase-3-trial-of-cabozantinib-atezolizumab-combo-in-prostate-cancer/ 2020-07-03T11:49:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/goldfinch-bio-secures-100-million-in-series-b-financing/ 2020-07-03T11:51:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Goldfinch-Bio-Logo.png http://www.pharmajournalist.com/fda-approves-bavencio-as-first-line-maintenance-treatment-for-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma/ 2020-07-03T11:54:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-approves-mercks-keytruda-for-first-line-treatment-of-patients-with-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer/ 2020-07-03T11:56:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-grants-odd-for-prestige-biopharmas-pbp1510-anti-pauf-monoclonal-antibody-for-the-treatment-of-pancreatic-cancer/ 2020-07-03T12:11:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Prestige-Biopharma.jpg http://www.pharmajournalist.com/osteolabs-gmbh-provides-further-validation-for-use-of-osteotest-in-osteoporosis-and-early-stage-kidney-malfunction/ 2020-07-03T12:14:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/osteolabs-logo.jpg http://www.pharmajournalist.com/featured-speakers-for-2nd-annual-wearable-injectors-and-connected-devices-conference-2020/ 2020-07-06T10:10:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/300x250.jpg http://www.pharmajournalist.com/moderna-and-rovi-announce-collaboration-for-ous-fill-finish-manufacturing-of-modernas-covid-19-vaccine-candidate/ 2020-07-10T08:16:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/moderna-completes-enrollment-of-phase-2-study-of-its-mrna-vaccine-against-covid-19-mrna-1273/ 2020-07-10T08:20:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/kymera-and-sanofi-enter-into-strategic-partnership-to-advance-novel-protein-degrader-therapies-to-patients/ 2020-07-10T08:21:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/gsk-and-medicago-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-candidate-vaccine/ 2020-07-10T08:25:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/novavax-announces-1-6-billion-funding-from-operation-warp-speed/ 2020-07-10T08:27:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/NOVAVAX.jpg http://www.pharmajournalist.com/mylan-gets-approval-for-emergency-use-of-remdesivir-for-covid-19/ 2020-07-10T08:30:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/mylan-and-fujifilm-kyowa-kirin-biologics-announce-u-s-fda-approval-of-hulio-adalimumab-fkjp/ 2020-07-10T08:32:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/eib-and-ec-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing/ 2020-07-10T08:36:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/European-Investment-Bank.jpg http://www.pharmajournalist.com/emergent-signs-five-year-agreement-for-large-scale-drug-substance-manufacturing-for-jjs-lead-covid-19-vaccine-candidate/ 2020-07-10T08:38:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/medivir-and-scilifelab-enter-collaboration-on-potential-sars-cov-2-inhibitors/ 2020-07-10T08:41:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/proteinqure-collaborates-with-astrazeneca-to-design-novel-peptide-therapeutics/ 2020-07-10T08:43:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/zymeworks-announces-new-multispecific-antibody-collaboration-with-merck/ 2020-07-10T08:46:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Zymeworks.jpg http://www.pharmajournalist.com/numab-and-boehringer-enter-into-collaboration-to-develop-multi-specific-antibody-therapeutics-for-cancer-and-retinal-diseases/ 2020-07-10T08:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/xencor-and-atreca-enter-strategic-collaboration-to-discover-develop-and-commercialize-novel-t-cell-engaging-bispecific-antibodies/ 2020-07-10T09:07:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/turning-point-therapeutics-and-zai-lab-announce-exclusive-license-agreement-for-repotrectinib-in-greater-china/ 2020-07-10T09:07:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/TurningPoint.jpg http://www.pharmajournalist.com/unum-therapeutics-inc-announces-acquisition-of-kiq-llc/ 2020-07-10T09:09:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/UNUM-Therapeutics-Logo.jpg http://www.pharmajournalist.com/ascentage-pharma-announces-clinical-trial-collaboration-agreement-with-msd-to-evaluate-apg-115/ 2020-07-10T09:49:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Ascentage-Pharma.png http://www.pharmajournalist.com/hitgen-and-morphic-extend-drug-discovery-research-collaboration/ 2020-07-10T09:51:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hitgen-Logo.jpg http://www.pharmajournalist.com/pfizer-pledges-100-million-to-new-industry-fund-to-help-fight-growing-threat-of-antimicrobial-resistance/ 2020-07-10T09:52:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/concert-receives-fda-breakthrough-therapy-designation-for-ctp-543-for-the-treatment-of-alopecia-areata/ 2020-07-10T09:54:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/lynparza-olaparib-approved-in-the-eu-for-germline-brca-mutated-metastatic-pancreatic-cancer/ 2020-07-10T09:56:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/vor-biopharma-closes-110-million-series-b-financing/ 2020-07-10T09:59:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/VOR-Biopharma.jpg http://www.pharmajournalist.com/ridgeback-begins-enrolment-for-phase-2-covid-19-trial-of-eidd-2801/ 2020-07-10T10:04:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/corvus-pharmaceuticals-initiates-clinical-trial-of-novel-immunotherapy-for-patients-with-covid-19/ 2020-07-10T10:10:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Corvus-Pharma-Logo.png http://www.pharmajournalist.com/sunovion-announces-topline-results-from-global-phase-2-study-of-sep-4199-in-patients-with-bipolar-i-depression/ 2020-07-10T10:14:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/sunovion-logo.jpg http://www.pharmajournalist.com/regeneron-announces-start-of-regn-cov2-phase-3-covid-19-prevention-trial-in-collaboration-with-niaid/ 2020-07-10T10:16:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/mina-therapeutics-ltd-to-present-keynote-at-oligonucleotide-therapeutics-and-delivery-2020/ 2020-07-10T14:06:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide-Discovery.jpg http://www.pharmajournalist.com/vera-brinks-from-proqr-therapeutics-presenting-keynote-at-oligonucleotide-therapeutics-and-delivery-2020/ 2020-07-10T14:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide-Discovery.jpg http://www.pharmajournalist.com/envisagenics-presents-latest-case-study-at-oligonucleotide-therapeutics-and-delivery-2020/ 2020-07-10T14:07:12+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Oligonucleotide-Discovery.jpg http://www.pharmajournalist.com/novel-platforms-in-ocular-drug-delivery-workshop/ 2020-07-16T11:00:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Ophthalmic.jpg http://www.pharmajournalist.com/tonix-to-develop-precision-medicine-techniques-for-covid-19-vaccines-and-therapeutics/ 2020-07-17T11:34:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/novartis-launches-first-of-its-kind-not-for-profit-portfolio-of-medicines-for-symptomatic-treatment-of-covid-19/ 2020-07-17T11:40:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/hackensack-meridian-cdi-has-struck-a-covid-19-research-collaboration-with-merck/ 2020-07-17T11:43:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Hackensack-Meridian.jpg http://www.pharmajournalist.com/roche-provides-update-on-phase-iii-study-of-tecentriq-in-women-with-advanced-stage-ovarian-cancer/ 2020-07-17T11:46:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/new-data-from-phase-iiib-study-reinforces-safety-profile-of-roches-hemlibra-in-people-with-haemophilia-a/ 2020-07-17T11:48:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/roche-collaborates-with-blueprint-medicines-to-bring-a-new-treatment-to-people-with-ret-altered-cancers/ 2020-07-17T11:50:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/tremfya-approved-by-fda-as-the-first-selective-interleukin-il-23-inhibitor-for-active-psoriatic-arthritis/ 2020-07-17T11:53:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/pfizer-and-biontech-granted-fda-fast-track-designation-for-two-investigational-mrna-based-vaccine-candidates-against-sars-cov-2/ 2020-07-17T11:56:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/amgen-announces-additional-investment-in-beigene/ 2020-07-17T11:58:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/australias-first-covid-treatment-approved/ 2020-07-17T12:02:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/merus-and-caris-life-sciences-announce-collaboration-to-detect-nrg1-fusions-in-cancer-patients/ 2020-07-17T12:06:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/merus-logo.jpg http://www.pharmajournalist.com/revitope-and-junshi-enter-into-research-collaboration-and-license-agreement-to-explore-next-generation-immunotherapies/ 2020-07-17T12:09:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Revitope-Oncology.jpg http://www.pharmajournalist.com/ovid-and-angelini-enter-into-exclusive-license-agreement-to-develop-manufacture-and-commercialize-ov101/ 2020-07-17T12:14:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Ovid-Therepeutics-Logo.jpg http://www.pharmajournalist.com/medicago-begins-phase-i-clinical-trials-for-its-covid-19-vaccine-candidate/ 2020-07-17T12:18:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Medicago-Logo.png http://www.pharmajournalist.com/fate-therapeutics-announces-exclusive-license-agreement-with-baylor-college-of-medicine-for-rejection-resistant-ipsc-derived-cellular-therapies/ 2020-07-17T12:20:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Fate-Therapeutics-Logo.jpg http://www.pharmajournalist.com/sanofi-and-md-anderson-announce-strategic-collaboration-to-accelerate-oncology-research-and-development/ 2020-07-17T12:21:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/orchard-therapeutics-announces-global-license-agreements-for-stable-cell-line-technology-from-gsk/ 2020-07-17T12:24:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Orchard-Therapeutics.jpg http://www.pharmajournalist.com/novocure-announces-clinical-trial-collaboration-with-msd/ 2020-07-17T12:26:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Novocure-Logo.jpg http://www.pharmajournalist.com/oncorus-announces-clinical-trial-collaboration-with-merck/ 2020-07-17T12:32:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Oncorus-Logo.jpg http://www.pharmajournalist.com/humanigen-expands-partnership-with-catalent-biologics-to-manufacture-investigational-covid-19-therapeutic-candidate-lenzilumab/ 2020-07-17T12:34:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Humanigen_Logo.jpg http://www.pharmajournalist.com/bioaegis-therapeutics-receives-approval-to-proceed-with-phase-2-trial-of-its-gelsolin-covid-19-treatment/ 2020-07-17T12:38:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/european-commission-approves-third-nintedanib-indication-in-pulmonary-fibrosis/ 2020-07-17T12:41:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-for-inflazomes-inzomelid-for-the-treatment-of-caps/ 2020-07-17T12:52:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Inflazome-logo.jpg http://www.pharmajournalist.com/glenmark-commences-1000-patients-post-marketing-surveillance-study-with-covid-19-who-are-administered-fabiflu/ 2020-07-17T13:00:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg http://www.pharmajournalist.com/rocket-pharma-announces-first-patient-treated-in-phase-1-trial-of-rp-l301-gene-therapy-for-pyruvate-kinase-deficiency/ 2020-07-17T13:10:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/rocket-pharmaceuticals-logo.jpg http://www.pharmajournalist.com/exclusive-interview-with-matts-ramstorp-ahead-of-smis-2nd-annual-next-generation-pharmaceutical-cleanroom/ 2020-07-20T15:00:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/P-330-Cleanroom-Technology-2020-1200x627-Matts-Ramstorp-BioTekPro.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/07/P-330-Cleanroom-Technology-2020-1200x627-Matts-Ramstorp-BioTekPro.jpg http://www.pharmajournalist.com/dynavax-and-medigen-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-vaccine-candidate/ 2020-07-24T11:43:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/arcturus-announces-agreement-with-israeli-ministry-of-health-to-supply-covid-19-vaccine-candidate-lunar-cov19/ 2020-07-24T11:50:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Arcturus-Therapeutics.jpg http://www.pharmajournalist.com/pfizer-and-biontech-announce-an-agreement-with-u-s-government-for-up-to-600-million-doses-of-mrna-based-vaccine-candidate-against-sars-cov-2/ 2020-07-24T11:55:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/bavarian-nordic-and-adaptvac-sign-final-license-agreement-on-covid-19-vaccine/ 2020-07-24T11:58:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Bavarian-Nordic.jpg http://www.pharmajournalist.com/gilead-sciences-secures-exclusive-option-to-acquire-tizona-therapeutics-for-300-million/ 2020-07-24T12:00:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/acadia-announces-fda-accepted-for-filing-the-supplemental-new-drug-application-for-nuplazid/ 2020-07-24T12:03:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/grifols-acquires-10-stake-in-bloodbuy-cloud-based-marketplace-for-blood-products/ 2020-07-24T12:05:32+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Grifols.jpg http://www.pharmajournalist.com/gsk-and-curevac-announce-strategic-mrna-technology-collaboration/ 2020-07-24T12:14:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19/ 2020-07-24T12:16:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/jw-therapeutics-acquires-syracuse-biopharma-and-license-to-eureka-therapeutics-solid-tumor-technology-in-china/ 2020-07-24T12:18:25+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Eureka-Therapeutics-Logo.png http://www.pharmajournalist.com/clarity-pharmaceuticals-and-imaginab-to-collaborate-on-new-cancer-targets/ 2020-07-24T12:20:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/clarity-pharmaceuticals.png http://www.pharmajournalist.com/altimmune-announces-manufacturing-agreement-with-vigene-biosciences-for-adcovid/ 2020-07-24T12:22:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/altimmune_logo.png http://www.pharmajournalist.com/daiichi-sankyo-and-gustave-roussy-enter-innovative-research-collaboration-for-dxd-adcs-ds-1062-and-patritumab-deruxtecan/ 2020-07-24T12:23:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/cobomarsen-receives-orphan-drug-designation-from-the-fda-for-the-treatment-of-t-cell-lymphoma/ 2020-07-24T12:25:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/miragen-therapeutics.jpg http://www.pharmajournalist.com/synaffix-announces-expansion-of-collaboration-with-adc-therapeutics/ 2020-07-24T12:28:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/synaffix-logo.jpg http://www.pharmajournalist.com/inotrem-gets-clearance-to-launch-phase-2-trial-of-nangibotide-in-covid-19-patients/ 2020-07-24T12:31:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/INOTREM_Logo.png http://www.pharmajournalist.com/jazz-pharmaceuticals-gets-us-fda-approval-of-xywav-for-cataplexy-associated-with-narcolepsy/ 2020-07-24T12:33:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/xylocor-therapeutics-doses-patients-in-phase-1-2-trial-evaluating-novel-gene-therapy-xc001-in-refractory-angina/ 2020-07-24T12:35:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/xylocor-therapeutics-logo.jpg http://www.pharmajournalist.com/jnana-therapeutics-enters-collaboration-with-roche-for-small-molecule-drugs/ 2020-07-24T12:38:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/genscript-launches-cdmo-segment-genscript-probio/ 2020-07-24T12:44:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/GenScript.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/07/GenScript.jpg http://www.pharmajournalist.com/astellas-partners-with-labcentral-to-help-emerging-biotechs-accelerate-preclinical-scientific-research/ 2020-07-24T12:47:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/just-evotec-biologics-to-produce-monoclonal-antibody-products-against-covid-19-for-the-department-of-defense/ 2020-07-24T12:49:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/evotec.jpg http://www.pharmajournalist.com/nexelis-acquires-integrated-bioanalytical-cro-ait-bioscience/ 2020-07-24T12:51:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Nexelis-Logo.jpg http://www.pharmajournalist.com/sangamo-announces-global-collaboration-with-novartis-to-develop-genomic-medicines-for-autism-and-other-neurodevelopmental-disorders/ 2020-07-31T10:24:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/teva-announces-new-strategic-focus-in-the-japanese-market/ 2020-07-31T10:26:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/single-dose-of-johnson-johnson-covid-19-vaccine-candidate-demonstrates-robust-protection-in-pre-clinical-studies/ 2020-07-31T10:28:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/intravacc-and-celonic-to-develop-and-produce-a-novel-covid-19-vaccine/ 2020-07-31T10:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/intravacc-logo.jpg http://www.pharmajournalist.com/ucb-enters-into-collaboration-with-roche-to-develop-antibody-treatment-for-people-living-with-alzheimers-disease/ 2020-07-31T10:45:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/dfc-to-sign-letter-of-interest-for-investment-in-kodaks-expansion-into-pharmaceuticals/ 2020-07-31T10:49:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/DFC-to-Sign-Letter.png http://www.pharmajournalist.com/wp-content/uploads/2020/07/DFC-to-Sign-Letter.png http://www.pharmajournalist.com/sanofi-and-gsk-agree-with-the-uk-government-to-supply-up-to-60-million-doses-of-covid-19-vaccine/ 2020-07-31T10:50:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/sandoz-announces-plans-for-joint-investment-to-help-strengthen-future-of-antibiotics-manufacturing-in-europe/ 2020-07-31T10:52:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/emergent-biosolutions-signs-agreement-with-astrazeneca-to-expand-manufacturing-for-covid-19-vaccine-candidate/ 2020-07-31T10:53:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/emergent-biosolutions_logo.jpg http://www.pharmajournalist.com/astrazeneca-and-daiichi-sankyo-enter-collaboration-to-develop-and-commercialise-new-antibody-drug-conjugate/ 2020-07-31T10:55:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/moderna-announces-phase-3-cove-study-of-mrna-vaccine-against-covid-19-mrna-1273-begins/ 2020-07-31T10:58:25+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/harbour-biomed-announces-strategic-partnership-with-viva-biotech-to-collaborate-on-incubating-innovative-biotech-start-ups/ 2020-07-31T11:00:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/piramal-announces-integrated-development-program-with-bolt-biotherapeutics/ 2020-07-31T11:02:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Piramal-Pharma-Solutions-Logo.png http://www.pharmajournalist.com/viva-biotech-and-schrodinger-announce-strategic-collaboration-to-generate-and-interrogate-structures-for-unsolved-targets/ 2020-07-31T11:04:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/01/Schrodinger-Logo.png http://www.pharmajournalist.com/karuna-therapeutics-and-psychogenics-announce-drug-discovery-collaboration/ 2020-07-31T11:06:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Karuna_Logo.jpg http://www.pharmajournalist.com/cerevel-and-cyclica-announce-research-collaboration-to-use-artificial-intelligence-in-neuroscience/ 2020-07-31T11:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/cerevel-logo.jpg http://www.pharmajournalist.com/zentalis-pharmaceuticals-enters-into-clinical-collaboration-with-eli-lilly/ 2020-07-31T11:12:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/zentalis_logo.jpg http://www.pharmajournalist.com/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-176-for-seasonal-influenza/ 2020-07-31T11:14:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/SAB-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/takeda-announces-fda-breakthrough-therapy-designation-granted-for-pevonedistat-for-the-treatment-of-patients-with-hr-mds/ 2020-07-31T11:16:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-approves-roches-tecentriq-plus-cotellic-and-zelboraf-for-people-with-advanced-melanoma/ 2020-07-31T11:18:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/neoimmunetech-gets-ind-clearance-for-nt-i7-trial-in-locally-recurrent-scchn/ 2020-07-31T11:20:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/neoimmunetech-logo.jpg http://www.pharmajournalist.com/new-speaker-session-with-kiniksa-pharmaceuticals-at-pre-filled-syringes-east-coast-2020/ 2020-08-03T14:19:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-EC.jpg http://www.pharmajournalist.com/pre-filled-syringes-san-francisco-will-now-take-place-as-a-virtual-conference/ 2020-08-04T12:05:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/ophthalmic-drug-delivery-development-trials-and-tribulations-workshop/ 2020-08-04T12:10:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Ophthalmic.jpg http://www.pharmajournalist.com/fda-approves-gsks-blenrep-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma/ 2020-08-07T03:57:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/teva-and-alvotech-announce-strategic-partnership-to-collaborate-in-the-u-s-biosimilar-market/ 2020-08-07T03:58:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/merck-and-hanmi-enter-into-licensing-agreement-to-develop-efinopegdutide/ 2020-08-07T04:00:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/sanofi-and-gsk-in-advanced-discussions-with-european-union-to-supply-up-to-300-million-doses-of-covid-19-vaccine/ 2020-08-07T04:02:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/pfizer-and-biontech-to-supply-japan-with-120-million-doses-of-their-bnt162-mrna-based-vaccine-candidate/ 2020-08-07T04:04:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/jj-announces-agreement-with-u-s-government-for-100-million-doses-of-investigational-covid-19-vaccine/ 2020-08-07T04:06:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/lorbrena-lorlatinib-significantly-improves-progression-free-survival-in-first-line-alk-positive-lung-cancer/ 2020-08-07T04:09:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/seismic-bio-partners-with-twist-bioscience-for-discovery-and-optimization-of-antibodies/ 2020-08-07T04:10:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Twist-Bioscience-logo.jpg http://www.pharmajournalist.com/myr-pharmaceuticals-receives-conditional-marketing-authorization-by-the-european-commission-for-hepcludex/ 2020-08-07T04:12:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/MYR-Pharma-Logo.png http://www.pharmajournalist.com/reviral-announces-fda-fast-track-designation-granted-to-sisunatovir/ 2020-08-07T04:15:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immunitybios-had5-vaccine-candidate-for-covid-19-succeeds-in-preclinical-study/ 2020-08-07T04:17:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/abcellera-provides-covid-19-program-update-with-the-start-of-phase-3-clinical-trials-and-the-expansion-of-its-covid-19-antibody-database/ 2020-08-07T04:29:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/fda-approves-roches-tecentriq-plus-cotellic-and-zelboraf-for-people-with-advanced-melanoma-2/ 2020-08-07T04:30:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/innovent-announces-first-patient-dosed-in-the-phase-1-clinical-trial-of-anti-cd47-pd-l1-bispecific-antibody-in-china/ 2020-08-07T04:32:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/innovent-biologics-logo.png http://www.pharmajournalist.com/g1-therapeutics-and-simcere-announce-exclusive-license-agreement-for-trilaciclib-in-greater-china/ 2020-08-07T04:35:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/G1-Therapeutics-Logo.png http://www.pharmajournalist.com/cellix-bio-pharma-completes-the-acquisition-of-avaca-pharma/ 2020-08-07T04:38:09+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Cellix-Logo.png http://www.pharmajournalist.com/caprion-histogenex-and-viroclinics-ddl-announce-a-strategic-partnership/ 2020-08-07T04:39:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/evotec-and-secarna-pharmaceuticals-form-strategic-partnership-in-the-field-of-antisense-therapy/ 2020-08-07T05:01:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/evotec.jpg http://www.pharmajournalist.com/medipal-holdings-partners-with-cryoport-to-bring-temperature-controlled-supply-chain-solutions-to-the-japanese-market/ 2020-08-07T05:03:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Cryoport-Logo.jpg http://www.pharmajournalist.com/catalent-adds-potent-manufacturing-capabilities-at-its-buenos-aires-argentina-site/ 2020-08-07T05:04:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/smis-pharmaceutical-microbiology-east-coast-conference-a-virtual-conference-with-remote-access-only/ 2020-08-12T16:24:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Microbiology-EC.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/07/Microbiology-EC.jpg http://www.pharmajournalist.com/genecentric-therapeutics-enters-into-research-collaboration-with-janssen/ 2020-08-14T01:54:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/celleron-enters-into-a-license-agreement-with-roche-to-improve-the-lives-of-patients-living-with-tenosynovial-giant-cell-tumour/ 2020-08-14T01:56:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/ligand-to-acquire-pfenex-inc/ 2020-08-14T01:59:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/verastem-oncology-signs-definitive-agreement-to-sell-copiktra-duvelisib-rights-to-secura-bio/ 2020-08-14T02:01:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/verastem-logo.png http://www.pharmajournalist.com/fda-approves-genentechs-evrysdi-risdiplam-for-treatment-of-spinal-muscular-atrophy-sma-in-adults-and-children-2-months-and-older/ 2020-08-14T02:05:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/pfizer-announces-agreement-with-gilead-to-manufacture-remdesivir-for-treatment-of-covid-19/ 2020-08-14T02:06:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/novavax-and-takeda-announce-collaboration-for-novavax-covid-19-vaccine-candidate-in-japan/ 2020-08-14T02:08:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-accepts-biogens-aducanumab-biologics-license-application-for-alzheimers-disease-with-priority-review/ 2020-08-14T02:09:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biogen-and-denali-sign-parkinsons-drug-deal-worth-2bn/ 2020-08-14T02:11:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/qbiotics-announces-clinical-collaboration-with-msd-targeting-unresectable-melanoma/ 2020-08-14T02:13:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/viva-and-langhua-reached-the-strategic-acquisition-agreement-accelerating-the-escalation-of-the-service-chain-of-innovative-drug-industry/ 2020-08-14T02:17:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/monopar-and-northstar-partner-with-isotherapeutics-for-the-manufacturing-of-potential-therapeutic-for-severe-covid-19/ 2020-08-14T02:18:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/agc-biologics-expands-partnership-with-novavax/ 2020-08-14T02:20:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/bayer-to-acquire-uk-based-biotech-kandy-therapeutics-ltd/ 2020-08-14T02:22:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/ana-therapeutics-and-quotient-sciences-announce-partnership-to-manufacture-niclosamide-drug-candidate-as-a-potential-treatment-for-covid-19/ 2020-08-14T02:23:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Quotient-Sciences-Logo.jpg http://www.pharmajournalist.com/blade-therapeutics-updates-enrolment-progress-for-covid-19-pneumonia-study-of-bld-2660/ 2020-08-14T02:26:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Blade-Therapeutics-Logo.jpg http://www.pharmajournalist.com/moderna-announces-supply-agreement-with-u-s-government-for-initial-100-million-doses-of-mrna-vaccine-against-covid-19-mrna-1273/ 2020-08-14T02:27:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/phase-iii-inpedild-trial-enrolls-first-patient-to-evaluate-nintedanib-in-pediatric-population-with-fibrosing-interstitial-lung-disease/ 2020-08-14T02:29:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/checkmate-577-trial-for-opdivo-meets-primary-endpoint-of-disease-free-survival/ 2020-08-14T02:31:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/sab-biotherapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-sab-185-for-the-treatment-and-prevention-of-covid-19/ 2020-08-14T02:33:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/SAB-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/fda-clears-appili-therapeutics-to-expand-its-phase-2-clinical-trial-of-favipiravir-for-the-potential-prevention-of-covid-19-at-u-s-long-term-care-facilities/ 2020-08-14T02:35:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/gilead-submits-application-to-fda-for-veklury-for-the-treatment-of-covid-19/ 2020-08-14T02:39:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/fda-approves-lampit-nifurtimox-for-the-treatment-of-chagas-disease-in-children/ 2020-08-14T02:41:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/exclusive-video-released-with-co-chairs-of-pre-filled-syringes-san-francisco-conference/ 2020-08-24T11:11:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Pre-filled-Syringes-San-Francisco.jpg http://www.pharmajournalist.com/exclusive-interview-with-forwardvue-pharma-released-for-ophthalmic-drugs-2020/ 2020-08-24T12:33:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Ophthalmic.jpg http://www.pharmajournalist.com/pharmasources-launches-the-export-driven-event-cphi-p-mec-china-e-trade-season/ 2020-08-25T09:09:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/cphi-file.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/08/cphi-file.jpg http://www.pharmajournalist.com/pharmasources-com-to-help-propel-the-chinese-api-export-business-with-e-trade-session-cphi-china-top-api-exporters-products/ 2020-08-25T09:17:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Pharmasources.jpg http://www.pharmajournalist.com/digital-5th-predict-3d-oncology-tissue-models-summit/ 2020-08-26T08:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/3D-Tissue-Models_Pharma-Journalist-Banner.png http://www.pharmajournalist.com/european-commission-signs-first-covid-19-vaccine-contract-with-astrazeneca/ 2020-08-27T19:54:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/European-Commission.jpg http://www.pharmajournalist.com/akers-biosciences-and-premas-biotech-announce-sars-cov-2-positive-proof-of-concept-results/ 2020-08-28T08:19:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/engitix-signs-collaboration-and-licensing-agreement-with-takeda-to-develop-anti-fibrotic-therapies-in-advanced-liver-diseases/ 2020-08-28T08:22:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/abbvie-harvard-university-form-research-alliance-to-address-emergent-viral-diseases/ 2020-08-28T08:24:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/sanofi-to-acquire-principia-biopharma/ 2020-08-28T08:29:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/bristol-myers-squibb-enters-agreement-to-acquire-forbius/ 2020-08-28T08:33:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/kohlberg-and-mubadala-sign-a-definitive-agreement-to-acquire-majority-stake-in-pci-pharma-services/ 2020-08-28T08:40:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg http://www.pharmajournalist.com/sab-biotherapeutics-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-sab-185-for-the-treatment-of-covid-19/ 2020-08-28T11:56:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/SAB-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/renalytixai-to-collaborate-with-astrazeneca-to-improve-outcomes-for-patients-with-chronic-disease/ 2020-08-28T11:59:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/bio-thera-solutions-and-beigene-announce-license-distribution-and-supply-agreement-for-avastin-bevacizumab-biosimilar-bat1706-in-china/ 2020-08-28T12:01:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/BeiGene-Logo.png http://www.pharmajournalist.com/harbour-biomed-signs-strategic-collaboration-agreement-with-vir-biotechnology/ 2020-08-28T12:05:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/hitgen-and-almirall-announce-achievement-of-milestone-in-their-strategic-collaboration/ 2020-08-28T12:07:33+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Hitgen-Logo.jpg http://www.pharmajournalist.com/epivax-announces-licensing-of-covid-19-vaccine-candidate-to-epivax-therapeutics/ 2020-08-28T12:10:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/EpiVax-Logo.png http://www.pharmajournalist.com/medgenome-announces-strategic-collaboration-in-parkinsons-disease-with-denali-therapeutics/ 2020-08-28T12:13:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Medgenome-Logo.jpg http://www.pharmajournalist.com/ivy-brain-tumor-center-and-vivace-therapeutics-collaborate-to-test-targeted-agent-in-glioblastoma-and-meningioma/ 2020-08-28T12:19:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/piramal-to-collaborate-with-epirium-bio-on-exclusive-integrated-development-manufacturing-program-for-orphan-drugs/ 2020-08-28T12:23:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Piramal-Pharma-Solutions.jpg http://www.pharmajournalist.com/rocket-pharmaceuticals-receives-fda-fast-track-designation-for-rp-l401-gene-therapy-for-infantile-malignant-osteopetrosis/ 2020-08-28T12:27:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/beigene-announces-exclusive-license-agreement-for-neutralizing-covid-19-antibodies-developed-by-singlomics-biopharmaceuticals/ 2020-08-28T12:34:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/Beigene.jpg http://www.pharmajournalist.com/novartis-investigational-novel-stamp-inhibitor-asciminib-abl001-meets-primary-endpoint-of-phase-iii-chronic-myeloid-leukemia-study/ 2020-08-28T12:36:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/hifibio-therapeutics-submits-ind-application-for-fully-human-sars-cov-2-neutralizing-antibody-for-the-treatment-of-covid-19-patients/ 2020-08-28T12:39:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/acadia-pharmaceuticals-acquires-cersci-therapeutics-adds-novel-pain-program-to-portfolio/ 2020-08-28T12:44:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/ACADIA-Pharma-Logo.jpg http://www.pharmajournalist.com/catalent-signs-agreement-with-astrazeneca-to-expand-manufacturing-support-for-covid-19-vaccine-azd1222/ 2020-08-28T12:46:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/registration-is-now-open-for-the-pre-filled-syringes-and-injectable-devices-conference-2021/ 2020-09-03T13:17:01+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/300-x-250.jpg http://www.pharmajournalist.com/heuft-to-host-a-free-exclusive-webinar-on-pulsed-x-ray-technology-smart-optics-for-a-total-inspection-of-pre-fillable-syringe-cannulas-and-needle-shields/ 2020-09-07T12:06:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/casma-therapeutics-announces-50-million-series-b-financing/ 2020-09-12T03:22:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Casma-Therapeutics-Logo.jpg http://www.pharmajournalist.com/bayer-collaborates-with-recursion-to-strengthen-digital-drug-discovery-and-advance-new-therapies-for-fibrotic-diseases/ 2020-09-12T03:23:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/fda-approves-trelegy-ellipta-as-the-first-once-daily-single-inhaler-triple-therapy-for-the-treatment-of-both-asthma-and-copd-in-the-us/ 2020-09-12T03:26:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/huadong-medicine-and-exscientia-enter-co-development-partnership-to-accelerate-oncology-drug-discovery-through-artificial-intelligence/ 2020-09-12T03:28:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Exscientia-Logo.png http://www.pharmajournalist.com/mylan-to-acquire-aspens-thrombosis-business-in-europe/ 2020-09-12T03:30:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/takeda-announces-results-from-phase-3-clinical-trial-evaluating-ninlaro-ixazomib-in-newly-diagnosed-multiple-myeloma/ 2020-09-12T03:32:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/destiny-pharma-and-sporegen-announce-collaboration-and-innovate-uk-grant-award-to-co-develop-novel-preventative-treatment-for-covid-19/ 2020-09-12T03:34:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/grifols-to-acquire-alkahest-for-146m/ 2020-09-12T03:40:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Grifols.jpg http://www.pharmajournalist.com/abbvie-and-i-mab-enter-into-global-strategic-partnership-for-differentiated-immuno-oncology-therapy/ 2020-09-12T03:41:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/ligand-expands-omniab-antibody-discovery-platform-through-the-acquisitions-of-xcella-biosciences-and-taurus-biosciences/ 2020-09-12T03:51:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/digital-health-what-are-the-real-world-opportunities-and-potential-barriers-to-adoption/ 2020-09-14T13:27:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/smi-logo.png http://www.pharmajournalist.com/boehringer-and-click-therapeutics-enter-into-collaboration-to-develop-and-commercialize-ct-155/ 2020-09-15T04:38:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/anheart-licenses-two-clinical-stage-oncology-candidates-from-daiichi-sankyo/ 2020-09-15T04:41:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/anges-and-brickell-biotech-announce-a-collaboration-agreement-for-the-development-of-a-novel-dna-vaccine-candidate-for-covid-19-in-the-u-s/ 2020-09-15T04:42:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/exelixis-and-nbe-therapeutics-enter-into-exclusive-collaboration-and-license-option-agreement-to-discover-and-develop-novel-antibody-drug-conjugates-for-the-treatment-of-cancer/ 2020-09-15T04:45:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/jazz-pharmaceuticals-announces-new-research-collaboration-with-redx-pharma-to-discover-and-develop-two-targeted-cancer-therapies/ 2020-09-15T04:46:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/agex-therapeutics-and-lineage-cell-therapeutics-announce-expansion-of-agreement-related-to-esi-clinical-grade-pluripotent-stem-cell-lines-for-therapeutic-purposes/ 2020-09-15T04:48:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/06/AGEX_Logo.jpg http://www.pharmajournalist.com/humanized-chicken-antibody-technology-to-drive-next-generation-of-integral-moleculars-mps-antibody-discovery-platform/ 2020-09-15T04:50:47+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Integral-Molecular-Logo.jpg http://www.pharmajournalist.com/harbour-biomed-and-hualan-genetic-announced-collaboration-to-develop-multiple-innovative-antibody-programs/ 2020-09-15T04:52:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/06/Harbour-BioMed-Logo.jpg http://www.pharmajournalist.com/gilead-sciences-to-acquire-immunomedics/ 2020-09-15T04:54:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/immune-regulation-ltd-receives-notice-of-allowance-for-new-u-s-patent-for-its-novel-protein-with-anti-inflammatory-properties/ 2020-09-15T04:57:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/immune-regulation-logo.jpg http://www.pharmajournalist.com/icanomab-gmbh-founded-with-private-funding-to-develop-precision-canonical-monoclonal-antibodies-in-oncology-immune-modulation-acute-inflammation-and-most-urgently-for-covid-19/ 2020-09-15T04:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/IcanoMAB-Logo.jpg http://www.pharmajournalist.com/pfizer-and-biontech-propose-expansion-of-pivotal-covid-19-vaccine-trial/ 2020-09-15T05:03:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/scibite-launches-state-of-the-art-ai-platform-for-life-sciences-organisations/ 2020-09-15T05:05:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/SciBite-Logo.jpg http://www.pharmajournalist.com/tjoapack-invests-in-automated-injectables-packaging-capabilities/ 2020-09-15T05:09:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Tjoapack.jpg http://www.pharmajournalist.com/pfizer-and-biontech-announce-data-from-preclinical-studies-of-mrna-based-vaccine-candidate-against-covid-19/ 2020-09-15T05:11:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/seneca-therapeutics-licenses-tumor-endothelial-marker-8-tem8-to-enable-better-patient-selection-for-svv-001-therapy/ 2020-09-15T05:43:41+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Seneca-Therapeutics-Logo.jpg http://www.pharmajournalist.com/applied-biomath-announces-collaboration-with-flame-biosciences-for-systems-pharmacology-modeling-in-lung-cancer/ 2020-09-15T05:49:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/applied-biomath-logo.png http://www.pharmajournalist.com/revision-therapeutics-announces-license-with-cornell-to-develop-treatment-for-stargardt-disease/ 2020-09-15T05:53:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Revision.jpg http://www.pharmajournalist.com/gilead-sciences-and-jounce-therapeutics-announce-exclusive-license-agreement-for-novel-immunotherapy-program/ 2020-09-15T05:55:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/igyxos-and-selexis-enter-service-agreement-to-advance-igyxos-first-in-class-monoclonal-antibody-for-the-treatment-of-human-infertility/ 2020-09-15T05:57:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Selexis-Cell-Line-Development.jpg http://www.pharmajournalist.com/biomx-enters-collaboration-with-boehringer-ingelheim-with-the-goal-of-discovering-microbiome-based-biomarkers-for-inflammatory-bowel-disease/ 2020-09-15T05:58:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/biomxlogo.png http://www.pharmajournalist.com/kite-and-hifibio-therapeutics-partner-to-discover-novel-targets-and-antibodies-against-acute-myeloid-leukemia/ 2020-09-15T06:00:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Kite-Pharma.jpg http://www.pharmajournalist.com/ppd-and-lupus-therapeutics-collaborate-to-support-lupus-clinical-research/ 2020-09-15T06:01:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/ehave-signs-licensing-agreement-to-enhance-its-telemedicine-platform/ 2020-09-15T06:05:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sotio-acquires-rights-to-boxr-car-t-platform-and-products-from-unum-therapeutics/ 2020-09-15T06:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Sotio-Logo.jpg http://www.pharmajournalist.com/nestle-to-acquire-aimmune-therapeutics/ 2020-09-15T06:15:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Nestle-Health-Science.png http://www.pharmajournalist.com/ionis-pharmaceuticals-to-acquire-remaining-stake-in-akcea-therapeutics/ 2020-09-15T06:17:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/oxford-biomedica-signs-supply-agreement-with-astrazeneca-to-expand-manufacturing-support-of-covid-19-vaccine-candidate-azd1222/ 2020-09-15T06:19:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/oxford-biomedica.jpg http://www.pharmajournalist.com/kite-submits-sbla-to-fda-for-yescarta-in-relapsed-or-refractory-indolent-non-hodgkin-lymphomas/ 2020-09-15T06:23:08+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Kite-Pharma.jpg http://www.pharmajournalist.com/santhera-exercises-option-to-obtain-worldwide-rights-to-vamorolone-in-duchenne-muscular-dystrophy-and-all-other-indications/ 2020-09-15T06:27:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/05/Santhera-Pharma-Logo.jpg http://www.pharmajournalist.com/who-updates-clinical-care-guidance-with-corticosteroid-recommendations/ 2020-09-15T06:30:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/WHO-Logo.jpg http://www.pharmajournalist.com/enesi-pharma-to-develop-thermostable-solid-dose-dna-vaccine-targeting-zika-virus-under-new-partnership-with-the-university-of-adelaide/ 2020-09-15T06:32:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/11/Enesi-Pharma-Logo.jpg http://www.pharmajournalist.com/fda-approves-additional-doses-of-trulicity-dulaglutide-for-the-treatment-of-type-2-diabetes/ 2020-09-15T06:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/sanofi-and-gsk-initiate-phase-1-2-clinical-trial-of-covid-19-adjuvanted-recombinant-protein-based-vaccine-candidate/ 2020-09-15T06:36:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/vir-biotechnology-and-gsk-start-phase-2-3-study-of-covid-19-antibody-treatment/ 2020-09-15T06:39:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/vor-biopharma-and-metagenomi-to-collaborate-on-engineered-hematopoietic-stem-cell-therapies/ 2020-09-15T06:47:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/VOR-Biopharma-Logo.png http://www.pharmajournalist.com/palleon-pharmaceuticals-raises-100-million-series-b-to-develop-drugs-targeting-glycan-mediated-immune-regulation-to-treat-cancer-and-inflammatory-diseases/ 2020-09-17T23:38:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Palleon-Pharma-Logo.jpg http://www.pharmajournalist.com/moderna-and-vertex-establish-new-collaboration-to-treat-cystic-fibrosis-using-gene-editing/ 2020-09-17T23:40:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/pitt-scientists-discover-tiny-antibody-component-that-is-highly-effective-in-preventing-and-treating-sars-cov-2-infection-in-animal-models/ 2020-09-17T23:43:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Pitt-Scientist.jpg https://pharmajournalist.com/wp-content/uploads/2020/09/Pitt-Scientist.jpg http://www.pharmajournalist.com/biontech-to-acquire-gmp-manufacturing-site-to-expand-covid-19-vaccine-production-capacity-in-first-half-2021/ 2020-09-17T23:46:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/biontech-to-receive-up-to-e375m-in-funding-from-german-federal-ministry-of-education-and-research-to-support-covid-19-vaccine-program-bnt162/ 2020-09-17T23:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/takeda-opens-new-rd-cell-therapy-manufacturing-facility-to-support-expansion-of-next-generation-clinical-programs/ 2020-09-17T23:51:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Takeda-RD-Cell.jpg https://pharmajournalist.com/wp-content/uploads/2020/09/Takeda-RD-Cell.jpg http://www.pharmajournalist.com/ansa-biotechnologies-raises-9-2-million-in-combined-seed-and-pre-seed-financing/ 2020-09-17T23:54:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Funds.jpg http://www.pharmajournalist.com/valneva-announces-major-covid-19-vaccine-partnership-with-u-k-government/ 2020-09-17T23:56:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/valneva-and-dynavax-announce-commercial-supply-agreement-for-inactivated-adjuvanted-covid-19-vaccine/ 2020-09-17T23:58:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/07/Valneva-Logo.png http://www.pharmajournalist.com/seattle-genetics-and-merck-announce-two-strategic-oncology-collaborations/ 2020-09-18T00:01:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/moderna-and-chiesi-group-establish-collaboration-to-discover-and-develop-mrna-therapeutics-for-pah/ 2020-09-18T00:04:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/curasen-therapeutics-announces-first-subjects-dosed-in-phase-1-clinical-trial-with-first-proprietary-compound-cst-2032-targeting-neurodegenerative-disease/ 2020-09-18T00:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/gileads-magrolimab-an-investigational-anti-cd47-monoclonal-antibody-receives-fda-breakthrough-therapy-designation-for-treatment-of-myelodysplastic-syndrome/ 2020-09-18T00:07:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/melior-pharmaceuticals-awarded-grant-for-advancing-pulmonary-therapeutic-in-covid-19-phase-2-clinical-trial/ 2020-09-18T00:10:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Melior_Pharm_Logo.jpg http://www.pharmajournalist.com/daiichi-sankyo-initiates-phase-2-study-of-patritumab-deruxtecan-in-patients-with-her3-expressing-advanced-colorectal-cancer/ 2020-09-18T00:13:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/hifibio-therapeutics-announces-a-global-strategic-partnership-with-abl-bio-for-the-co-development-of-a-sars-cov-2-neutralizing-antibody/ 2020-09-18T00:15:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/baricitinib-in-combination-with-remdesivir-reduces-time-to-recovery-in-hospitalized-patients-with-covid-19-in-niaid-sponsored-actt-2-trial/ 2020-09-18T00:16:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/samsung-biologics-signs-development-agreement-with-panolos-for-solid-tumor-treatment/ 2020-09-18T00:18:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/junshi-and-wigen-enter-global-development-and-commercialization-collaboration-for-four-small-molecule-cancer-drug-candidates/ 2020-09-18T00:21:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Junshi-Biosciences.jpeg http://www.pharmajournalist.com/humanigen-and-lonza-announce-collaboration-to-expand-manufacturing-of-humanigens-covid-19-therapeutic-candidate-lenzilumab/ 2020-09-18T00:22:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/axovant-and-viralgen-sign-strategic-gene-therapy-development-and-manufacturing-partnership/ 2020-09-18T00:24:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Axovant_Gene_Therapies.png http://www.pharmajournalist.com/novus-therapeutics-announces-acquisition-of-anelixis-therapeutics/ 2020-09-18T00:27:39+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/novus-logo.jpg http://www.pharmajournalist.com/medical-fair-asia-2020-goes-digital-with-online-convenience-for-medical-sourcing-needs/ 2020-09-22T09:00:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/05/MFA2020_VP_PharmaJournalists_300X250px.png http://www.pharmajournalist.com/new-speaker-session-with-bsi-at-pre-filled-syringes-east-coast-2020/ 2020-09-22T10:33:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-EC.jpg http://www.pharmajournalist.com/purify20-this-high-profile-event-on-chromatography-purification-to-be-held-in-hyderabad/ 2020-09-23T10:04:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/purify-1.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/09/purify-1.jpg http://www.pharmajournalist.com/jyseleca-filgotinib-approved-in-japan-for-rheumatoid-arthritis/ 2020-09-25T15:42:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/rdif-and-chemrar-to-supply-avifavir-to-17-countries/ 2020-09-25T15:52:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/RFID.jpg http://www.pharmajournalist.com/fda-accepts-supplemental-nda-for-pfizers-xalkori-crizotinib-for-the-treatment-of-pediatric-alk-positive-anaplastic-large-cell-lymphoma/ 2020-09-25T15:55:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/novartis-provides-update-on-avxs-101-intrathecal-clinical-development-program/ 2020-09-25T15:56:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-kisqali-receives-the-highest-rating-of-any-cdk4-6-inhibitor-on-the-esmo-magnitude-of-clinical-benefit-scale/ 2020-09-25T15:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-piqray-data-show-survival-benefit-for-patients-with-hr-her2-advanced-breast-cancer-with-a-pik3ca-mutation/ 2020-09-25T16:01:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/sanofi-and-gsk-sign-agreements-with-the-government-of-canada-to-supply-up-to-72-million-doses-of-adjuvanted-covid-19-vaccine/ 2020-09-25T16:09:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/permira-funds-to-acquire-cns-specialty-pharmaceutical-company-neuraxpharm/ 2020-09-25T16:12:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/PERMIRA-Logo.png http://www.pharmajournalist.com/scenic-biotech-enters-into-genetic-modifier-collaboration-with-genentech/ 2020-09-25T16:15:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Scenic-Biotech-Logo.jpg http://www.pharmajournalist.com/bausch-health-to-acquire-option-to-purchase-all-ophthalmology-assets-of-allegro-ophthalmics/ 2020-09-25T16:18:36+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Bausch-Health.jpg http://www.pharmajournalist.com/samsung-biologics-signs-strategic-partnership-with-kanaph-therapeutics-to-develop-treatment-for-retinal-diseases/ 2020-09-25T16:22:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Samsung-Biologics-Kanaph.png http://www.pharmajournalist.com/roche-receives-positive-chmp-opinion-for-tecentriq-in-combination-with-avastin-for-the-treatment-of-people-with-the-most-common-form-of-liver-cancer/ 2020-09-25T16:24:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sanofi-and-gsk-will-provide-up-to-300-million-doses-of-covid-19-vaccine-to-the-european-union/ 2020-09-25T16:26:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/abcellera-and-igm-biosciences-announce-multi-year-antibody-discovery-collaboration/ 2020-09-25T16:29:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/lumen-bioscience-awarded-federal-grant-to-rapidly-develop-nanobody-based-covid-19-therapeutic/ 2020-09-25T17:12:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Lumen-Bioscience-Logo.jpg http://www.pharmajournalist.com/insysbio-announces-its-collaboration-with-genmab/ 2020-09-25T17:17:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Insysbio-logo.png http://www.pharmajournalist.com/anokion-announces-expansion-of-exclusive-collaboration-with-bristol-myers-squibb-to-develop-novel-treatments-for-autoimmune-diseases/ 2020-09-25T17:19:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Anokion.jpg http://www.pharmajournalist.com/lantern-pharma-announces-collaboration-and-research-agreement-with-fox-chase-cancer-center-focused-on-advancing-the-development-of-lp-184-in-pancreatic-cancer/ 2020-09-25T17:21:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Lantern-Pharma-Logo.png http://www.pharmajournalist.com/collplant-and-united-therapeutics-announce-exercise-of-option-that-will-expand-their-collaboration-to-include-3d-bioprinting-of-human-kidneys-for-transplant/ 2020-09-25T17:23:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/3D-Bioprinting.jpg https://pharmajournalist.com/wp-content/uploads/2020/09/3D-Bioprinting.jpg http://www.pharmajournalist.com/cend-therapeutics-announces-acquisition-of-impilo-therapeutics/ 2020-09-25T17:28:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Cend-Therapeutics-Logo.png http://www.pharmajournalist.com/t-knife-and-catalent-sign-technology-transfer-and-manufacturing-agreement-for-autologous-t-cell-receptor-based-cell-therapy/ 2020-09-25T17:29:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/millendo-therapeutics-announces-initiation-of-first-in-human-clinical-trial-of-mle-301-a-selective-nk3r-antagonist/ 2020-09-25T17:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/micreos-initiates-clinical-trial-to-evaluate-worlds-first-endolysin-drug-as-a-therapy-for-atopic-dermatitis/ 2020-09-25T17:35:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/Endolysin.jpg https://pharmajournalist.com/wp-content/uploads/2020/09/Endolysin.jpg http://www.pharmajournalist.com/leading-microbiologists-to-meet-at-smis-10th-annual-pharmaceutical-microbiology-conference/ 2020-09-29T13:07:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/P-337-Pharma-Microbiology-UK-300x250-1.jpg http://www.pharmajournalist.com/heuft-to-host-a-free-exclusive-pre-filled-syringes-webinar/ 2020-10-02T11:11:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/WP-003v2-Combined-Speakers.gif http://www.pharmajournalist.com/wp-content/uploads/2020/10/WP003-1200x627v2.gif http://www.pharmajournalist.com/eisai-and-seikagaku-enter-into-agreement-for-the-marketing-alliance-of-si-613-a-treatment-of-osteoarthritis-in-south-korea/ 2020-10-02T14:52:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/fujifilm-concludes-a-manufacturing-contract-agreement-with-vlp-therapeutics-for-a-covid-19-vaccine-formulation/ 2020-10-02T14:57:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/orgenesis-announces-agreement-to-acquire-koligo-therapeutics-a-leader-in-personalized-cell-therapies/ 2020-10-02T15:02:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/pfizer-receives-fda-fast-track-designation-for-duchenne-muscular-dystrophy-investigational-gene-therapy/ 2020-10-02T15:03:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-approves-pfizers-xeljanz-tofacitinib-for-the-treatment-of-active-polyarticular-course-juvenile-idiopathic-arthritis/ 2020-10-02T15:06:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/ai-drug-rd-startup-xtalpi-announces-over-300-million-series-c-investment-led-by-softbank-vision-fund-picc-capital-and-morningside/ 2020-10-02T15:08:40+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/XtalPi-logo.png http://www.pharmajournalist.com/abbvie-gets-orphan-drug-and-fast-track-status-for-elezanumab/ 2020-10-29T15:09:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/fda-approves-nucala-as-the-first-and-only-biologic-treatment-for-hypereosinophilic-syndrome-hes/ 2020-10-02T15:12:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/avrobio-receives-orphan-drug-designation-from-the-european-medicines-agency-for-avr-rd-02-an-investigational-gene-therapy-for-gaucher-disease/ 2020-10-02T15:16:18+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Avrobio-Logo.jpg http://www.pharmajournalist.com/vor-biopharma-and-arbor-biotechnologies-to-collaborate-on-engineered-hematopoietic-stem-cell-therapies/ 2020-10-02T15:17:59+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/VOR-Biopharma-Logo.png http://www.pharmajournalist.com/fibrogenesis-announces-manufacturing-agreement-with-ibiologics/ 2020-10-02T15:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/FibroGenesis-Logo.jpg http://www.pharmajournalist.com/cstone-pfizer-enter-into-strategic-collaboration-to-address-oncological-needs-in-china/ 2020-10-02T15:23:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sermonix-pharmaceuticals-partners-with-exactis-innovation-for-elaine-1-clinical-trial-sites-in-canada/ 2020-10-02T15:25:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Sermonix-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/sorrento-therapeutics-and-viralclear-enter-into-agreement-to-explore-combination-antibody-plus-antiviral-therapy-against-covid-19/ 2020-10-02T15:27:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/covis-group-announces-agreement-to-acquire-amag-pharmaceuticals/ 2020-10-02T15:28:56+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/alnylam-reports-positive-results-from-illuminate-b-phase-3-study-of-lumasiran/ 2020-10-02T15:31:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/kuur-therapeutics-announces-first-patients-dosed-with-allogeneic-car-nkt-cell-therapy/ 2020-10-02T15:35:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Kuur_Therapeutics.jpg http://www.pharmajournalist.com/siegfried-to-acquire-two-pharmaceutical-manufacturing-sites-from-novartis-in-spain/ 2020-10-02T15:42:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Siegfried.jpg http://www.pharmajournalist.com/sterling-pharma-solutions-acquires-api-facility-in-us/ 2020-10-02T15:54:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Sterling-Pharma.jpg http://www.pharmajournalist.com/catalent-launches-onexpress-solution-to-accelerate-oral-dosage-products-from-clinic-to-launch/ 2020-10-02T15:57:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/lonza-launches-the-pyrocell-monocyte-activation-test-system-for-reliable-and-sustainable-in-vitro-pyrogen-testing/ 2020-10-02T15:59:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/challenges-and-drivers-for-development-of-long-acting-injectables/ 2020-10-06T08:52:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/7th-annual-world-adc-awards-winners-whats-next/ 2020-10-06T09:09:46+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/World-ADC-Awards.png http://www.pharmajournalist.com/exclusive-interview-with-maria-jose-lopez-barragan-formerly-fda-released-ahead-of-pharmaceutical-microbiology-east-coast-2020/ 2020-10-07T07:54:35+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/1200x627-Maria-Jose-Lopez-Barragan-FDA-Virtual.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/10/1200x627-Maria-Jose-Lopez-Barragan-FDA-Virtual.jpg http://www.pharmajournalist.com/registration-is-now-open-for-rna-therapeutics-2021/ 2020-10-07T09:46:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2020.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/10/RNA-2020.jpg http://www.pharmajournalist.com/takeda-and-arrowhead-collaborate-to-co-develop-and-co-commercialize-aro-aat-for-alpha-1-antitrypsin-associated-liver-disease/ 2020-10-09T11:09:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/biontech-and-pfizer-initiate-rolling-submission-to-european-medicines-agency-for-sars-cov-2-vaccine-candidate-bnt162b2/ 2020-10-09T11:13:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/nvidia-announces-partnership-with-gsks-ai-powered-lab-for-discovery-of-medicines-and-vaccines/ 2020-10-09T11:15:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/bristol-myers-squibb-to-acquire-myokardia-for-13-1-billion-in-cash/ 2020-10-09T11:19:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/bone-therapeutics-link-health-and-pregene-to-develop-and-commercialize-the-allob-allogeneic-bone-cell-therapy-platform-in-china-and-southeast-asia/ 2020-10-09T11:26:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Bone-Therapeutics-Logo.png http://www.pharmajournalist.com/nimble-announces-strategic-research-collaboration-with-incyte-to-discover-novel-peptide-based-therapeutics/ 2020-10-09T11:42:26+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/springworks-therapeutics-announces-clinical-collaboration-with-pfizer-inc-to-evaluate-nirogacestat-in-combination-with-pf%e2%80%9006863135/ 2020-10-09T11:47:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/SpringWorks-Logo.png http://www.pharmajournalist.com/aro-collaboration-with-ionis-advances-with-option-exercise/ 2020-10-09T11:59:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Aro-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/scribe-therapeutics-to-collaborate-with-biogen-to-develop-crispr-based-genetic-medicines-for-neurological-diseases-including-amyotrophic-lateral-sclerosis/ 2020-10-09T12:04:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Scribe-Therapeutics-Logo.jpg http://www.pharmajournalist.com/citius-pharmaceuticals-signs-an-exclusive-worldwide-licensing-agreement-with-novellus-therapeutics/ 2020-10-09T12:07:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Citius-Pharma-Logo.png http://www.pharmajournalist.com/olix-announces-expansion-of-collaboration-with-laboratoires-thea-to-develop-sirna-therapeutics-for-ophthalmic-diseases/ 2020-10-09T12:10:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Olix-Pharma-Logo.jpg http://www.pharmajournalist.com/qualigen-therapeutics-enters-into-commercialization-agreement-for-its-fastpack-diagnostic-products-in-china/ 2020-10-09T12:14:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/noxopharm-announces-first-covid-19-patient-treated-in-veyonda-study/ 2020-10-09T12:17:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/jj-announces-european-commission-approval-of-agreement-to-supply-200-million-doses-of-janssens-covid-19-vaccine-candidate/ 2020-10-09T12:48:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/pfizer-and-sangamo-dose-first-participant-in-phase-3-study-evaluating-hemophilia-a-gene-therapy-treatment/ 2020-10-09T12:51:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-broadly-supports-oragenics-pre-ind-development-program-for-its-sars-cov-2-vaccine/ 2020-10-09T12:52:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/vir-biotechnology-and-gsk-announce-global-expansion-to-phase-3-of-comet-ice-study-evaluating-vir-7831-for-the-treatment-of-covid-19/ 2020-10-09T12:54:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/eureka-therapeutics-announces-initiation-of-arya-1-clinical-trial-to-evaluate-et140203-artemis-t-cell-therapy-in-hepatocellular-carcinoma/ 2020-10-09T12:55:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Eureka-Therapeutics-Logo.png http://www.pharmajournalist.com/fda-grants-glycomimetics-rare-pediatric-disease-designation-for-rivipansel-for-treatment-of-sickle-cell-disease/ 2020-10-09T12:57:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immunogen-announces-fda-breakthrough-therapy-designation-for-imgn632-in-relapsed-or-refractory-blastic-plasmacytoid-dendritic-cell-neoplasm/ 2020-10-09T12:58:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Immunogen-Logo.png http://www.pharmajournalist.com/fda-approves-opdivo-yervoy-combo-for-previously-untreated-unresectable-mpm/ 2020-10-09T13:02:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/registration-closing-soon-for-pre-filled-syringes-east-coast-2020/ 2020-10-12T09:34:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/PFS-EC.jpg http://www.pharmajournalist.com/smis-3d-cell-culture-conference-2021-speakers-announced/ 2020-10-12T12:07:52+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/P-340-300x250-VIRTUAL.jpg http://www.pharmajournalist.com/lilly-announces-agreement-to-acquire-disarm-therapeutics/ 2020-10-19T09:19:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-ebola-virus/ 2020-10-19T09:21:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/boehringer-and-oxford-biotherapeutics-expand-collaboration-to-discover-novel-selective-tumor-targets-as-first-bispecific-antibody-advanced-into-the-clinic/ 2020-10-19T09:23:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/moderna-announces-initiation-of-rolling-submission-to-health-canada-for-mrna-vaccine-against-covid-19-mrna-1273/ 2020-10-19T09:25:48+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/cstone-announces-completion-of-200-million-share-sale-to-pfizer/ 2020-10-19T09:28:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/forxiga-recommended-for-approval-in-the-eu-by-chmp-for-heart-failure/ 2020-10-19T09:31:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/orchard-therapeutics-receives-positive-chmp-opinion-for-libmeldy-for-the-treatment-of-early-onset-metachromatic-leukodystrophy-mld/ 2020-10-19T09:33:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/07/Orchard-Therapeutics.jpg http://www.pharmajournalist.com/allogene-therapeutics-and-md-anderson-announce-strategic-collaboration-to-accelerate-advancement-of-allogeneic-car-t-therapy/ 2020-10-19T09:35:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/09/Allogene-Therapeutics-Logo.png http://www.pharmajournalist.com/dyno-therapeutics-enters-collaboration-and-license-agreement-with-roche-to-develop-next-generation-aav-gene-therapy-vectors-for-cns-diseases-and-liver-directed-therapies/ 2020-10-19T09:36:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/nestle-completes-acquisition-of-aimmune-therapeutics/ 2020-10-19T09:39:34+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Nestle.jpg http://www.pharmajournalist.com/twist-bioscience-and-neogene-announce-broad-strategic-partnership-for-next-generation-personalized-t-cell-therapies/ 2020-10-19T09:41:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Twist-Bioscience-logo.jpg http://www.pharmajournalist.com/axis-therapeutics-announces-research-collaboration-with-pharmaessentia-for-development-of-tcr-t-cell-therapy-in-taiwan/ 2020-10-19T09:43:30+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Axis-Therapeutics-Logo.png http://www.pharmajournalist.com/gannex-received-u-s-ind-approval-for-its-nash-drug-candidate-asc42%ef%bc%8can-fxr-agonist/ 2020-10-19T09:45:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/ascletis-logo.jpg http://www.pharmajournalist.com/dr-reddys-and-rdif-receive-approval-to-conduct-clinical-trial-for-sputnik-v-vaccine-in-india/ 2020-10-19T09:48:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/sanofi-and-translate-bio-mrna-covid-19-vaccine-candidate-induced-high-antibody-levels-in-preclinical-studies/ 2020-10-19T09:51:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-approves-expanded-indication-for-mercks-keytruda-pembrolizumab-in-adult-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma-chl/ 2020-10-19T09:52:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-authorizes-phase-1-trial-of-immunitybios-novel-covid-19-vaccine-candidate-had5-dual-construct-is-designed-to-drive-both-t-cell-and-antibody-immunity/ 2020-10-19T09:55:15+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/y-mabs-announces-fda-clearance-of-ind-for-its-lutetium-177-labeled-omburtamab-antibody/ 2020-10-19T09:58:10+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/YmAbs_Logo.jpg http://www.pharmajournalist.com/astellas-and-seagen-announce-positive-topline-results-from-second-cohort-of-patients-in-phase-2-pivotal-trial-of-padcev-enfortumab-vedotin-ejfv-in-advanced-urothelial-cancer/ 2020-10-19T10:00:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/hitgen-to-acquire-vernalis-a-leader-in-structure-based-drug-discovery/ 2020-10-19T10:02:05+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/pre-filled-syringes-and-injectable-devices-conference-2021-goes-virtual/ 2020-10-19T10:52:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/PFS-UPDATED.jpg http://www.pharmajournalist.com/rna-therapeutics-2021-is-now-a-virtual-conference/ 2020-10-19T15:35:55+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/RNA-2021.jpg http://www.pharmajournalist.com/extractables-and-leachables-usa-online-2020/ 2020-10-22T12:23:20+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/el-sm-090920.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/10/el-sm-090920.jpg http://www.pharmajournalist.com/purdue-pharma-reaches-agreement-with-u-s-department-of-justice/ 2020-10-23T10:15:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Purdue-Pharma.jpg http://www.pharmajournalist.com/immunitybio-nantkwest-announce-first-patient-dosed-in-phase-1-clinical-trial-of-second-generation-covid-19-vaccine-candidate-delivering-both-spike-and-nucleocapsid-of-sars-cov-2/ 2020-10-23T10:18:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/COVID-vaccine-first-patient.jpg http://www.pharmajournalist.com/wp-content/uploads/2020/10/COVID-vaccine-first-patient.jpg http://www.pharmajournalist.com/novartis-receives-fda-orphan-drug-designation-for-branaplam-lmi070-in-huntingtons-disease-hd/ 2020-10-23T10:19:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/open-orphan-hvivo-signs-contract-with-uk-government-for-the-development-of-a-covid-19-human-challenge-study-model/ 2020-10-23T10:21:44+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Open-Orphan.jpg http://www.pharmajournalist.com/symvivo-corporation-receives-funding-for-covid-19-vaccine-program/ 2020-10-23T10:23:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/edesa-biotech-receives-approval-to-initiate-covid-19-study-in-the-u-s/ 2020-10-23T10:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/akron-biotech-signs-agreement-with-synairgen-plc-to-supply-interferon-beta-for-covid-19-treatment/ 2020-10-23T10:30:14+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Akron-Biotech-Logo.jpg http://www.pharmajournalist.com/ngm-expands-oncology-portfolio-with-first-immuno-oncology-development-candidate-ngm707-a-novel-dual-antagonist-antibody-inhibiting-ilt2-and-ilt4/ 2020-10-23T11:00:19+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/ngmbio-logo.png http://www.pharmajournalist.com/genesis-therapeutics-enters-ai-driven-multi-target-drug-discovery-partnership-with-genentech/ 2020-10-23T11:02:31+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Genesis-Therapeutics-Logo.jpg http://www.pharmajournalist.com/immune-therapeutics-announces-signing-of-definitive-merger-agreement-between-cytocom-and-cleveland-biolabs/ 2020-10-23T11:04:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/immune-therapeutics-logo.jpg http://www.pharmajournalist.com/roche-and-prothena-will-advance-prasinezumab-into-late-stage-clinical-development-study-in-parkinsons-disease/ 2020-10-23T11:05:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/hemoshear-therapeutics-enters-into-rare-liver-disease-research-collaboration-with-takeda/ 2020-10-23T11:08:07+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Hemoshear-Therapeutics-Logo.jpg http://www.pharmajournalist.com/teneobio-announces-a-research-collaboration-and-license-agreement-with-arsenalbio/ 2020-10-23T11:10:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Teneobio-Logo.png http://www.pharmajournalist.com/avalon-globocare-and-adial-announce-strategic-collaboration-for-global-distribution-of-covid-19-point-of-care-antibody-rapid-test-devices/ 2020-10-23T11:12:22+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/catalent-and-brainstorm-cell-therapeutics-announce-partnership-for-the-manufacture-of-mesenchymal-stem-cell-platform-therapy-nurown/ 2020-10-23T11:14:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/fda-approves-gileads-antiviral-veklury-remdesivir-for-treatment-of-covid-19/ 2020-10-23T11:16:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/gilead-announces-new-data-on-biktarvy-for-the-treatment-of-hiv-in-black-americans/ 2020-10-23T11:17:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/tagrisso-granted-priority-review-in-the-us-for-the-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer/ 2020-10-23T11:19:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/xeris-granted-fast-track-designation-by-the-fda-for-its-novel-concentrated-diazepam-formulation-xp-0863-for-injection/ 2020-10-23T11:21:23+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Xeris-Logo.jpg http://www.pharmajournalist.com/fda-grants-fast-track-designation-for-asp0367-ma-0211-a-selective-ppar%ce%b4-modulator-being-developed-for-the-treatment-of-primary-mitochondrial-myopathies/ 2020-10-23T11:23:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/jsr-life-sciences-expands-its-european-gene-to-gmp-biologics-manufacturing-facilities-for-selexis-and-kbi-biopharma-in-geneva-switzerland/ 2020-10-23T11:24:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/jsr-life-sciences-image.jpg http://www.pharmajournalist.com/vifor-pharma-and-cara-therapeutics-sign-us-license-agreement-for-iv-korsuva-to-treat-dialysis-patients-with-pruritus/ 2020-10-23T11:26:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/02/Vifor-Pharma-Logo.jpg http://www.pharmajournalist.com/registration-closing-soon-for-2nd-digital-exosome-based-therapeutic-development-summit/ 2020-10-23T13:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Exosome-Based-Therapeutics-Pharma-Journalist.png http://www.pharmajournalist.com/wp-content/uploads/2020/10/Exosome-Based-Therapeutics-Pharma-Journalist.png http://www.pharmajournalist.com/cstone-and-legochem-biosciences-enter-global-licensing-agreement-for-new-antibody-drug-conjugate/ 2020-10-30T09:33:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/novartis-announces-collaboration-with-molecular-partners-to-develop-two-darpin-therapies-designed-for-potential-use-against-covid-19/ 2020-10-30T09:35:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/lilly-announces-agreement-with-u-s-government-to-supply-300000-vials-in-an-effort-to-fight-covid-19/ 2020-10-30T09:37:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/apellis-and-sobi-enter-collaboration-for-global-co-development-and-ex-us-commercialization-of-systemic-pegcetacoplan-in-rare-diseases-with-urgent-need-for-new-treatments/ 2020-10-30T09:38:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/moderna-announces-supply-agreement-with-the-ministry-of-public-health-to-supply-qatar-with-mrna-vaccine-against-covid-19-mrna-1273/ 2020-10-30T09:45:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/moderna-partners-with-takeda-and-the-government-of-japan-to-supply-50-million-doses-of-mrna-vaccine-against-covid-19-mrna-1273-to-japan/ 2020-10-30T09:47:16+00:00 https://pharmajournalist.com/wp-content/uploads/2020/03/Moderna.jpg http://www.pharmajournalist.com/ana-therapeutics-begins-phase-2-3-clinical-trial-of-proprietary-oral-niclosamide-formulation-to-treat-covid-19/ 2020-10-30T09:49:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/bayer-acquires-asklepios-biopharmaceutical-to-broaden-innovation-base-in-cell-and-gene-therapy/ 2020-10-30T09:51:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/gilead-sciences-completes-acquisition-of-immunomedics-inc/ 2020-10-30T09:52:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/fda-authorises-restart-of-the-covid-19-azd1222-vaccine-us-phase-iii-trial/ 2020-10-30T09:55:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/knight-signs-new-exclusive-ambisome-agreement-with-gilead-in-brazil/ 2020-10-30T10:05:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/10/Knight-Therapeutics.png http://www.pharmajournalist.com/sfj-pharmaceuticals-partner-apellis-enters-strategic-collaboration-with-sobi-to-develop-and-commercialize-pegcetacoplan-in-hematologic-indications-outside-the-u-s/ 2020-10-30T10:09:00+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/SFJ-Pharmaceuticals.png http://www.pharmajournalist.com/histogen-and-amerimmune-enter-into-a-collaborative-development-and-commercialization-agreement-for-emricasan-in-the-treatment-of-covid-19/ 2020-10-30T10:11:43+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Histogen-Logo.jpg http://www.pharmajournalist.com/insitro-announces-five-year-discovery-collaboration-with-bms-to-discover-and-develop-novel-treatments-for-amyotrophic-lateral-sclerosis-and-frontotemporal-dementia/ 2020-10-30T10:13:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/insitro-logo.png http://www.pharmajournalist.com/releviate-therapeutics-inks-exclusive-license-for-human-monoclonal-antibodies-for-chronic-pain-indications/ 2020-10-30T10:16:50+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Releviate-Logo.jpg http://www.pharmajournalist.com/abcellera-and-kodiak-sciences-enter-second-antibody-discovery-collaboration-for-ophthalmology-targets/ 2020-10-30T10:19:23+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/abcellera.jpg http://www.pharmajournalist.com/protagonist-therapeutics-announces-advancement-of-oral-il-23-receptor-antagonists-program-in-collaboration-with-janssen/ 2020-10-30T10:21:33+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/novartis-sickle-cell-medicine-adakveo-approved-in-europe-to-prevent-recurrent-vaso-occlusive-crises/ 2020-10-30T10:24:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/kala-pharmaceuticals-announces-fda-approval-of-eysuvis-for-the-short-term-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/ 2020-10-30T10:30:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/sanofi-and-gsk-to-support-covax-with-200-million-doses-of-adjuvanted-recombinant-protein-based-covid-19-vaccine/ 2020-10-30T10:37:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/hifibio-therapeutics-completes-first-cohort-of-a-phase-i-study-of-its-sars-cov-2-neutralizing-antibody-for-the-treatment-and-prevention-of-covid-19/ 2020-10-30T10:39:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/registration-is-now-open-for-smis-15th-annual-parallel-trade-conference-2021/ 2020-11-02T09:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Parallel-Trade-2021.jpg http://www.pharmajournalist.com/an-industry-outlook-latest-regulatory-challenges-in-pre-filled-syringe-innovation/ 2020-11-02T10:30:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/09/PFS-UPDATED.jpg http://www.pharmajournalist.com/less-than-6-weeks-to-go-until-the-3rd-rna-targeted-drug-discovery-summit/ 2020-11-03T09:28:45+00:00 https://pharmajournalist.com/wp-content/uploads/2020/08/RNA-TDD-2020.png http://www.pharmajournalist.com/bachem-group-webinar-on-cost-efficient-and-green-manufacturing-of-peptides-thanks-to-molecular-hiving-technology-announced/ 2020-11-03T11:29:38+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/300x300-Bachem-Group-Webinar.jpg http://www.pharmajournalist.com/merck-to-acquire-velosbio/ 2020-11-06T15:02:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/lynparza-approved-in-the-eu-for-the-treatment-of-brca-mutated-metastatic-castration-resistant-prostate-cancer/ 2020-11-06T15:04:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ec-approves-roches-tecentriq-in-combination-with-avastin-for-the-treatment-of-people-with-the-most-common-form-of-liver-cancer/ 2020-11-06T15:07:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sanofi-offers-to-acquire-kiadis-a-clinical-stage-company-developing-cell-based-immunotherapy-products/ 2020-11-06T15:10:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/ema-accepts-biogens-aducanumab-marketing-authorization-application-for-alzheimers-disease/ 2020-11-06T15:12:58+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/EISAI.jpg http://www.pharmajournalist.com/taysha-gene-therapies-bolsters-manufacturing-capacity-through-partnership-with-catalent/ 2020-11-06T15:15:49+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Taysha-Gene-Therapies.png http://www.pharmajournalist.com/isotopia-molecular-imaging-begins-clinical-supply-collaboration-with-y-mabs-therapeutics-inc/ 2020-11-06T15:18:17+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/isotopia-Logo.jpg http://www.pharmajournalist.com/axsome-therapeutics-and-veeva-systems-partner-to-build-axsomes-digital-centric-commercialization-platform/ 2020-11-06T15:20:54+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Axsome-Therapeutics-Logo.png http://www.pharmajournalist.com/tff-pharmaceuticals-and-felix-biotechnology-sign-letter-of-intent-for-a-collaboration-development-and-license-agreement/ 2020-11-06T15:23:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/TFF-Pharma.jpg http://www.pharmajournalist.com/tff-pharma-and-augmenta-bioworks-enter-into-a-worldwide-joint-development-agreement-for-covid-19-monoclonal-antibody-therapies/ 2020-11-06T15:25:29+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/TFF-Pharma.jpg http://www.pharmajournalist.com/zucara-therapeutics-expands-zt-01-development-program-to-type-2-diabetes/ 2020-11-06T15:27:27+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/zucara-logo.png http://www.pharmajournalist.com/telix-pharma-and-china-grand-pharma-announce-strategic-licence-and-commercial-partnership-for-greater-china-market/ 2020-11-06T15:29:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/nanology-enrolls-first-patient-in-phase-2-clinical-trial-of-nanopac-for-intratumoral-treatment-of-prostate-cancer/ 2020-11-06T15:33:06+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/NanOlogy-Logo.jpg http://www.pharmajournalist.com/xnk-therapeutics-receives-us-orphan-drug-status-for-nk-cell-based-immunotherapy-in-multiple-myeloma/ 2020-11-06T15:35:11+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/XNK-Therapeutics-Logo.png http://www.pharmajournalist.com/astrazenecas-forxiga-approved-in-the-eu-for-heart-failure/ 2020-11-06T15:37:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/gw-pharmaceuticals-initiates-pivotal-phase-3-study-of-nabiximols-for-multiple-sclerosis-associated-spasticity/ 2020-11-06T15:38:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/GWPharmaceuticalsLogo.jpg http://www.pharmajournalist.com/acg-acquires-significant-stake-in-mumbai-based-iqgen-x/ 2020-11-06T15:40:13+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/handshake.jpg http://www.pharmajournalist.com/ionis-and-akcea-announce-that-pfizer-has-initiated-a-phase-2b-clinical-study-of-vupanorsen-akcea-angptl3-lrx/ 2020-11-06T15:41:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/bristol-myers-squibb-announces-deucravacitinib-bms-986165-demonstrated-superiority-to-placebo-and-otezla-apremilast-in-pivotal-phase-3-psoriasis-study/ 2020-11-06T15:42:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/perkinelmer-to-acquire-cell-engineering-company-horizon-discovery-for-383-million-296-million/ 2020-11-06T15:45:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/introducing-the-gene-therapy-medical-affairs-summit/ 2020-11-12T10:34:28+00:00 https://pharmajournalist.com/wp-content/uploads/2020/10/Gene-Therapy-Medical-Affairs.png http://www.pharmajournalist.com/taiho-and-lung-therapeutics-enter-into-an-exclusive-license-agreement-in-japan-for-lti-01/ 2020-11-13T13:53:53+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Lung-Therapeutics-Logo.jpg http://www.pharmajournalist.com/brazils-national-health-surveillance-agency-authorizes-resumption-of-the-phase-iii-clinical-trial-of-coronavac/ 2020-11-13T13:57:04+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/pfizer-and-biontech-reach-an-agreement-to-supply-the-eu-with-200-million-doses-of-their-bnt162b2-mrna-based-vaccine-candidate-against-sars-cov-2/ 2020-11-13T13:58:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/termination-of-bridge-biotherapeuticss-collaboration-and-license-agreement-with-boehringer-ingelheim/ 2020-11-13T14:03:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-authorizes-monoclonal-antibody-for-treatment-of-covid-19/ 2020-11-13T14:05:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/immunitybio-nantkwest-announce-positive-interim-phase-1-safety-data-of-had5-covid-19-vaccine-dose-study/ 2020-11-13T14:07:02+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/immunitybios-had5-covid-19-vaccine-candidate-stimulates-memory-t-cell-recall-in-patients-infected-with-sars-cov-2/ 2020-11-13T14:08:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/ImmunityBio-Logo.png http://www.pharmajournalist.com/adagio-therapeutics-raises-80m-series-b-round-to-further-advance-best-in-class-antibodies-for-coronavirus-treatment-and-prevention/ 2020-11-13T14:09:24+00:00 https://pharmajournalist.com/wp-content/uploads/2020/04/Covid-19.jpg http://www.pharmajournalist.com/jubilant-therapeutics-and-onethree-biotech-collaborate-to-advance-precision-oncology/ 2020-11-13T14:19:51+00:00 https://pharmajournalist.com/wp-content/uploads/2020/11/Jubilant-Therapeutics-Logo.jpg http://www.pharmajournalist.com/xencor-morphosys-and-incyte-enter-into-global-development-collaboration-for-tafasitamab-in-combination-with-plamotamab/ 2020-11-13T14:25:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/medigen-and-bluewillow-biologics-partner-to-develop-intranasal-vaccine-for-sars-cov-2/ 2020-11-13T14:35:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Medigene-Logo.png